w66À´Àû¹ú¼Ê | NanoSynergy ÊÖÒÕÆ½Ì¨ Tue, 30 Sep 2025 06:45:34 +0000 zh-CN hourly 1 ÉÅʳGABAµÄÉñÃØÊµÁ¦£º£º£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³× /?p=40304 /?p=40304#comments Tue, 30 Sep 2025 06:06:00 +0000 http://www.jialanhai.com/?p=40304

ÉÅʳGABAµÄÉñÃØÊµÁ¦£º£º£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³×

2025-09-30 14:06

   GABA£¬£¬¼´¦Ã-°±»ù¶¡Ëᣬ£¬ÊÇÖÐÊàÉñ¾­ÏµÍ³ÖÐʩչҪº¦×÷ÓõÄÒÖÖÆÐÔÉñ¾­µÝÖÊ¡£Ëüͨ¹ýÓëGABAAºÍGABABÁ½ÖÖÀàÐ͵ÄÊÜÌåÏ໥×÷Ó㬣¬×ÊÖúµ÷Àí´óÄԺͼ¹ËèÖеÄÉñ¾­»î¶¯£¬£¬È·±£Éñ¾­ÐźÅת´ïµÄƽºâ¡£GABAµÄºÏ³ÉÒÀÀµÓڹȰ±ËáºÍάÉúËØB6£¬£¬¶øËüÔÚ´óÄÔÖÐµÄÆ½ºâ¹ØÓÚÔ¤·ÀºÍÖÎÁÆÄ³Ð©Éñ¾­ºÍ¾«Éñ¼²²¡ÖÁ¹ØÖ÷Òª¡£±ðµÄ£¬£¬GABA²»µ«ÔÚÉñ¾­ÏµÍ³ÄÚ²¿Ê©Õ¹×÷Ó㬣¬»¹Ó볦µÀ΢ÉúÎïȺÓйØÁª£¬£¬ÕâЩ΢ÉúÎïȺÄܹ»±¬·¢GABA£¬£¬½ø¶ø¿ÉÄÜͨ¹ý³¦µÀ-ÄÔÖáÓ°ÏìÇéÐ÷ºÍÈÏÖª¹¦Ð§[1]¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDkvNjI5YTFiMGY3MWIyNzEyYWRiNjE5OTVjOTAyMDdmZDUucG5n

չʾ³¦µÀ-´óÄÔÖṦЧ×÷ÓõÄÄâÒé»úÖÆµÄʾÒâͼ



 1¡¢¡¢ÉÅʳÖеÄGABA¶Ô˯ÃßµÄÓ°Ïì

   ÉÅʳÖеÄGABA¶Ô˯ÃßµÄDZÔÚÓ°ÏìÒÑÒýÆðÑо¿ÕßµÄÐËȤ£¬£¬ÓÉÓÚËü¿ÉÄÜͨ¹ýÔöǿ˯ÃßÖÊÁ¿ºÍ³ÖÐøÊ±¼äÀ´×ÊÖú¸ÄÉÆË¯Ãß¡£Ñо¿Åú×¢£¬£¬ÉãÈ븻º¬GABAµÄ´óÃ׿ÉÒÔ¸ÄÉÆÖÐÄ껼Õߺ;ø¾­ºó¸¾Å®µÄ˯Ãß״̬£¬£¬ÌØÊâÊÇÔÚïÔ̭˯ÃßDZÔÚÆÚºÍÌá¸ß˯ÃßЧÂÊ·½Ãæ¡£¶¯ÎïʵÑéÒ²Åú×¢£¬£¬GABAµÄÉãÈëÄܹ»ÔöÌíѪÇåÍʺڼ¤ËØË®Æ½£¬£¬ÕâÊÇÒ»ÖÖÖ÷ÒªµÄµ÷Àí˯Ãß-ÐѾõÖÜÆÚµÄ¼¤ËØ¡£±ðµÄ£¬£¬GABAÔö²¹¼ÁÔÚһЩСÐÍÁÙ´²ÊÔÑéÖÐÏÔʾ³öïÔ̭˯ÃßDZÔÚÆÚµÄÇ÷ÊÆ£¬£¬Ö»¹Ü¶ÔËùÓÐ˯Ãß²ÎÊýµÄÒ»ÖÂÐÔÓ°ÏìÉÐδ»ñµÃ֤ʵ¡£Ö»¹ÜЧ¹ûÒòÑо¿ºÍ²ÎÊý¶øÒ죬£¬µ«ÉÅʳGABA¶Ô˯Ãߵįð¾¢Ó°ÏìÊÇÏÔ¶øÒ×¼ûµÄ£¬£¬ÕâΪ½øÒ»²½Ñо¿ÌṩÁËÓÐÏ£ÍûµÄÆ«Ïò¡£Î´À´µÄÑо¿ÐèÒª±ê×¼»¯ÒªÁìºÍ¸üÆÕ±éµÄÑùÔ­À´¸üºÃµØÃ÷È·GABA×÷Ϊ˯Ã߸¨ÖúµÄDZÁ¦¡£

 2¡¢¡¢ÉÅʳÖÐGABA¶Ô½¹ÂǵÄÓ°Ïì


   ÉÅʳÖеÄGABA¶Ô½¹ÂǵÄÓ°ÏìÒѾ­»ñµÃÁËһЩÑо¿µÄÖ§³Ö¡£ÔÚ¶¯ÎïÄ£×ÓÖУ¬£¬¿Ú·þGABAÄÜÏÔÖøïÔÌ­ÇéÐ÷Ó¦¼¤ÒýÆðµÄ½¹ÂÇÑùÐÐΪ£¬£¬Í¨¹ýÌá¸ß¿ª·ÅÔ°µØÊÔÑéÖеÄÖÐÐÄÇøÓòÍ£Áôʱ¼äÒÔ¼°Ôڸ߼ÜÊ®×ÖÃÔ¹¬ÊÔÑéÖÐÔöÌí¿ª·Å±ÛµÄÍ£Áôʱ¼äÀ´ÌåÏÖ¡£±ðµÄ£¬£¬GABAµÄÉãÈ뻹ÓëѪ½¬ÖÐÒ»Ñõ»¯µª´úл²úÆ·µÄˮƽÏà¹Ø£¬£¬ÕâÅú×¢GABA¿ÉÄÜͨ¹ýÓ°ÏìÒ»Ñõ»¯µªµÄ´úлÀ´Ê©Õ¹Æä¿¹½¹ÂÇ×÷Óá£

   ÔÚÈËÀàÑо¿ÖУ¬£¬GABAÇ¿»¯Ê³Î£¬ÈçÇÉ¿ËÁ¦£¬£¬Í¨¹ýÐÄÂʱäÒìÐÔºÍÍÙÒºÖеÄÊȸõÁ£ÂѰ×AˮƽÀ´ÆÀ¹ÀѹÁ¦£¬£¬ÏÔʾ³ö½µµÍÐÄÀíѹÁ¦µÄDZÁ¦¡£ÕâЩÑо¿Ð§¹ûÅú×¢£¬£¬GABAÇ¿»¯Ê³Îï¿ÉÄÜͨ¹ýµ÷Àí×ÔÖ÷Éñ¾­ÏµÍ³»î¶¯ºÍÓ°ÏìÓëѹÁ¦Ïà¹ØµÄÉúÎï±ê¼ÇÎïÀ´ïÔÌ­½¹ÂǸС£

    3¡¢¡¢ÉÅʳÖÐGABA¶ÔÌÛÍ´µ÷ÀíµÄÓ°Ïì


   ÉÅʳGABA¶ÔÌÛÍ´µ÷ÀíµÄDZÔÚÓ°ÏìÊÇÌÛÍ´ÖÎÀíÑо¿µÄÒ»¸öÐÂÐËÁìÓò¡£GABA×÷ΪÖÐÊàÉñ¾­ÏµÍ³ÖеÄÒÖÖÆÐÔÉñ¾­µÝÖÊ£¬£¬Í¨¹ýµ÷ÀíÉñ¾­ÐË·ÜÐÔÔÚÌÛÍ´¸ÐÖªÖÐʩչҪº¦×÷Óá£Ñо¿·¢Ã÷£¬£¬GABAˮƽµÄ½µµÍÓëÉñ¾­²¡ÀíÐÔÌÛÍ´Ä£×ÓÖÐÌÛÍ´Ãô¸Ð¶ÈµÄÔöÌíÓйØ£¬£¬ÕâÖÖ½µµÍ¿ÉÄÜÊÇÓÉÓÚGABAºÏ³ÉÊÜË𡢡¢GABA±¬·¢Éñ¾­ÔªµÄËðʧ»òGABAתÔË»úÖÆµÄ¸Ä±ä¡£

   ¿Ú·þGABAÔö²¹¼Á×÷ΪһÖÖ¿ÉÄܵÄÖÎÁÆÊֶΣ¬£¬ÒÑÏÔʾ³öͨ¹ýÔöÌí¼¹ËèGABA»îÐÔÀ´¼õÇáÌÛÍ´µÄDZÁ¦¡£ÀýÈ磬£¬GABAÀàËÆÎïÒ©Î£¬Èç¼Ó°ÍÅç¶¡ºÍÆÕÈð°ÍÁÖ£¬£¬Í¨¹ýÓ°ÏìÌØ¶¨µÄÖÐÊàÉñ¾­ÏµÍ³Í¨µÀ£¬£¬ïÔÌ­Éñ¾­ÐË·Ü£¬£¬´Ó¶øÔÚÌÛÍ´ÖÎÁÆÖÐÏÔʾ³öЧ¹û¡£

   4¡¢¡¢ÉÅʳGABA¾ßÓÐÉñ¾­±£»£»£»¤ºÍÈÏÖªÔöÇ¿×÷ÓÃ

   ÉÅʳGABAÏÔʾÈëÃÔ¾­±£»£»£»¤ºÍÈÏÖªÔöÇ¿µÄDZÁ¦£¬£¬ÕâÖ÷ÒªµÃÒæÓÚÆäÔÚµ÷ÀíÉñ¾­ÐźÅת´ïÖеÄÒÖÖÆ×÷Óá£GABAÄܹ»Í¨¹ýÔö½øÒÖÖÆÐÔ×÷ÓúͼõÇáÉñ¾­ÔªµÄÌ«¹ýÐË·Ü£¬£¬À´ïÔÌ­Éñ¾­ËðÉ˺Íϸ°ûéæÃü£¬£¬´Ó¶ø·´¿¹ÐË·ÜÐÔ¶¾ÐÔ¡£ÔÚ¶¯ÎïÄ£×ÓÖУ¬£¬¿Ú·þGABA»òGABAÔö²¹¼ÁÒѱ»Ö¤ÊµÄܹ»¸ÄÉÆÑ§Ï°ºÍÓ°ÏóÌåÏÖ£¬£¬ÒÔ¼°Ó°Ïì´óÄÔÖÐGABAºÍ¹È°±ËáµÄº¬Á¿¡£

   ±ðµÄ£¬£¬GABAµÄÉãÈ뻹Óë¸ÄÉÆÈÏÖª¹¦Ð§Ïà¹Ø£¬£¬ÀýÈçÔÚÈËÀàÑо¿ÖУ¬£¬Ò»¶¨¼ÁÁ¿µÄGABAÉãÈë±»ÊӲ쵽¿ÉÒÔÌá¸ß×¢ÖØÁ¦Ñ¡ÔñºÍʱ¼ä×¢ÖØÁ¦Ê¹ÃüµÄÌåÏÖ¡£GABAµÄÕâЩ×÷ÓÿÉÄܶÔÖÎÁÆ´´ÉËÐÔÄÔËðÉ˺ÍÉñ¾­ÍËÐÐÐÔ¼²²¡µÈ¾ßÓÐÖ÷ÒªÒâÒå¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDkvYTlmNmNkM2RiNWM0MDhmMmFjZTA0YjgzZjYzM2U4YjUucG5n

Ð˷ܶ¾ÐÔ»úÖÆÓÕµ¼±í´ï GABA ºÍ¹È°±ËáÊÜÌåµÄϸ°û±¬·¢²¡Àíת±ä£¬£¬µ¼ÖÂϸ°ûéæÃü


   5¡¢¡¢³¦µÀ΢ÉúÎﱬ·¢µÄ GABA µÄ×÷ÓÃ

   ³¦µÀ΢ÉúÎïȺ±¬·¢µÄGABAÔÚµ÷ÀíÉñ¾­ÏµÍ³¹¦Ð§·½ÃæÊÎÑÝ×ÅÖ÷Òª½ÇÉ«¡£Ìض¨µÄ³¦µÀϸ¾ú£¬£¬ÈçÈéËá¸Ë¾úºÍË«Æç¸Ë¾ú£¬£¬Äܹ»½«¹È°±Ëáת»¯ÎªGABA¡£ÕâÖÖ΢ÉúÎïÔ´µÄGABAͨ¹ý³¦µÀ-ÄÔÖáÓ°ÏìÇéÐ÷ºÍÈÏÖª¹¦Ð§£¬£¬¿ÉÄܶÔÖÎÁƽ¹ÂÇ¡¢¡¢ÒÖÓôºÍÉñ¾­ÍËÐÐÐÔ¼²²¡¾ßÓÐDZÁ¦¡£Ñо¿Åú×¢£¬£¬³¦µÀ΢ÉúÎïȺµÄʧµ÷Óë¶àÖÖÉñ¾­ÏµÍ³¼²²¡ÓйØ£¬£¬¶øÍ¨¹ýÒæÉú¾úºÍÒûʳ¸ÉÔ¤µ÷Àí³¦µÀ΢ÉúÎïȺ£¬£¬¿ÉÄÜÓÐÖúÓÚ»Ö¸´GABAˮƽ£¬£¬¸ÄÉÆÉñ¾­¿µ½¡¡£

   6¡¢¡¢×ܽáºÍÕ¹Íû

   ÏÖÔÚ¶à·½ÃæµÄÑо¿ÉÅʳGABA¶ÔÉñ¾­ÏµÍ³£¬£¬°üÀ¨Æä¶Ô˯Ãß¡¢¡¢½¹ÂÇ¡¢¡¢ÌÛÍ´¡¢¡¢ÈÏÖªºÍѪѹµÄDZÔÚÒæ´¦¡£Ñо¿Åú×¢£¬£¬GABAÄܹ»Í¨¹ýѪÄÔÆÁÕÏ£¬£¬Ó°ÏìÉñ¾­µÝÖÊµÄÆ½ºâ£¬£¬¿ÉÄÜÓÐÖúÓÚ¸ÄÉÆÉñ¾­ºÍ¾«Éñ¿µ½¡¡£Ö»¹Ü¶¯ÎïÄ£×ÓºÍÆðÔ´ÈËÀàÑо¿ÌṩÁËÆð¾¢Ö¤¾Ý£¬£¬µ«ÈËÀàÊý¾ÝÓÐÏÞ£¬£¬ÐèÒª¸üÉîÈëµÄÑо¿À´È·¶¨GABAµÄ×î¼Ñ¼ÁÁ¿¡¢¡¢Åä·½ºÍºã¾ÃÓ°Ïì¡£±ðµÄ£¬£¬GABAµÄ΢ÉúÎïȺ±¬·¢Í¾¾¶Ò²Í»ÏÔÁ˳¦µÀ-ÄÔÖáÔÚÉñ¾­µ÷ÀíÖеÄÖ÷Òª×÷Ó㬣¬ÎªÎ´À´µÄ¸öÐÔ»¯ÓªÑøºÍÖÎÁÆÕ½ÂÔÌṩÁËÐÂ˼Ð÷¡£



²Î¿¼ÎÄÏ×

1. Almutairi S, Sivadas A, Kwakowsky A. The Effect of Oral GABA on the Nervous System: Potential for Therapeutic Intervention. Nutraceuticals. 2024;4(2):241-259. doi:10.3390/nutraceuticals4020015


·ÖÏíµ½£º£º£º

ÔĶÁ¸ü¶àÎÄÕÂ
READ MORE

]]> /?feed=rss2&p=40304 0 άÉúËØDÊÇά³ÖÈËÌ念½¡µÄÒªº¦Î¢Á¿ÓªÑøËØ /?p=40294 /?p=40294#comments Thu, 28 Aug 2025 06:45:44 +0000 http://www.jialanhai.com/?p=40294

ÉÅʳGABAµÄÉñÃØÊµÁ¦£º£º£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³×

2025-09-30 14:06

   

  άÉúËØD£¬£¬ÕâÖÖÖÁ¹ØÖ÷ÒªµÄ΢Á¿ÓªÑøËØ£¬£¬¶Ôw66À´Àû¹ú¼Ê¹Ç÷À¿µ½¡ºÍ¶àÖÖÐÄÀíÀú³ÌÆðמöÒéÐÔ×÷Óá£ÔÚÌåÄÚ£¬£¬Î¬ÉúËØDת»¯Îª25(OH)DºÍ1,25(OH)2D£¬£¬Óë¼××´ÅÔÏÙ¼¤ËØÐ­Í¬ÊÂÇ飬£¬ÒÔ׼ȷµ÷¿ØÑª¸ÆË®Æ½¡£×îеÄÑо¿Ò»Ö±Õ¹ÏÖάÉúËØDÔÚÔ¤·ÀÐÄѪ¹Ü¼²²¡¡¢¡¢×ÔÉíÃâÒß¼²²¡¡¢¡¢Ñ¬È¾ÒÔ¼°Ä³Ð©ÀàÐͰ©Ö¢·½ÃæµÄÒªº¦×÷Óá£2024Ä꣬£¬ÃÀ¹úÐÄÔà´úлºÍÄÚÉøÍ¸Ñо¿ËùµÄ×îÐÂÑо¿Ç¿µ÷£¬£¬ÎªÁËʵÏÖ¼²²¡Ô¤·ÀµÄ×î¼ÑЧ¹û£¬£¬½¨Ò齫25(OH)Dˮƽά³ÖÔÚ40ÖÁ80ng/mLµÄ¹æÄ£ÄÚ[1]¡£

  άÉúËØDȱ·¦µÄ½ç˵άÉúËØDȱ·¦£º£º£ºÑªÇå25(OH)DŨ¶ÈµÍÓÚ40ng/mL£¬£¬ÎÞ·¨Öª×ãÆäÐÄÀíºÍÉúÎ﹦ЧµÄÐèÇó¡£ÑÏÖØÎ¬ÉúËØDȱ·¦£º£º£ºÑªÇå25(OH)DŨ¶ÈµÍÓÚ12ng/mL£¬£¬´Ëʱ¸öÌå¿ÉÄ᷺ܻÆðÓëάÉúËØDȱ·¦Ïà¹ØµÄÖ¢×´¡£Î¬ÉúËØD¸»×㣺£º£ºÑªÇå25(OH)DŨ¶È¸ßÓÚ50ng/mL£¬£¬ÕâÊÇά³ÖÕûÌ念½¡ºÍǿ׳ÐÄÀí¹¦Ð§Ëù±ØÐèµÄ¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvZmMzZWQ1MTk2NGE0ZThkZDc5MTVlZWQ5MmE0YmM1YmUucG5n


1. Î¬ÉúËØDµÄÖ÷ÒªÐÔ¼°È«Çòȱ·¦ÏÖ×´


  άÉúËØDÊÇά³ÖÈËÌ念½¡µÄ±ØÐè΢Á¿ÓªÑøËØ£¬£¬¶Ô¹Ç÷À¿µ½¡ÓÈÆäÖ÷Òª¡£ËüÔÚÌåÄÚת»¯Îª25(OH)DºÍ1,25(OH)2D£¬£¬Óë¼××´ÅÔÏÙ¼¤ËØÅäºÏµ÷ÀíѪ¸ÆË®Æ½£¬£¬Ó°ÏìÉñ¾­¼¡È⹦Ч¡£Î¬ÉúËØD»¹¶ÔÔ¤·À¶àÖÖ¼²²¡ÓÐÆð¾¢×÷Ó㬣¬°üÀ¨ÐÄѪ¹Ü²¡¡¢¡¢´úл¼²²¡¡¢¡¢×ÔÉíÃâÒß¼²²¡¡¢¡¢Ñ¬È¾ºÍijЩ°©Ö¢¡£Î¬ÉúËØDȱ·¦»á¼Ó¾çÑ×Ö¢ºÍ´úлÔÓÂÒ£¬£¬ÔöÌíѬȾ·çÏÕ¡£Òò´Ë£¬£¬Î¬³ÖѪÇå25(OH)DˮƽÔÚ40ng/mLÒÔÉ϶Կµ½¡ÖÁ¹ØÖ÷Òª¡£

  È«ÇòÁè¼Ý°ëÊýµÄÈËÒòȱ·¦ÈÕɹ¶øÎ¬ÉúËØDȱ·¦£¬£¬ÓÈÆäÔÚÔ¶Àë³àµÀµÄµØÇø¡£Îª¸ÄÉÆÕâһ״̬£¬£¬ÐèÒªÌá¸ß¹«ÖÚ¶ÔÇå¾²ÈÕɹ¡¢¡¢ÒûʳȪԴºÍÔö²¹Î¬ÉúËØDµÄÊìϤ¡£Ä¿½ñµÄάÉúËØDÉãÈ뽨Òéͨ³£Î´ÄÜÖª×ãÈËÌåÐèÇ󣬣¬ÓÉÓÚËüÃÇûÓÐ˼Á¿µ½Î¬ÉúËØDÔÚ¼²²¡Ô¤·À·½ÃæµÄ×÷Óá£È«Çò¹æÄ£ÄÚ£¬£¬ÓÉÓÚÈÕɹȱ·¦ºÍ×èÖ¹Ñô¹âµÄÐÐΪ£¬£¬Î¬ÉúËØDȱ·¦ÆÕ±é±£´æ£¬£¬µ¼ÖÂÁè¼Ý°ëÊýµÄÉú³ÝѪÇå25(OH)DˮƽµÍÓÚ40ng/mL¡£ÕâÖÖȱ·¦×´Ì¬¿ÉÄÜ»á¼Ó¾ç¶àÖÖ¼²²¡£¬£¬ÔöÌíÆäËû¼²²¡µÄÒ׸ÐÐÔ¡£

  ΪÁ˸ÄÉÆÕâһ״̬£¬£¬ÐèÒªÌá¸ß¹«ÖÚ¶ÔάÉúËØDÖ÷ÒªÐÔµÄÊìϤ£¬£¬ÃãÀøÇå¾²µÄÈÕɹϰ¹ß£¬£¬ÔöÌíÒûʳÖÐάÉúËØDµÄÉãÈ룬£¬²¢ÔÚÐëҪʱÔö²¹¡£Ö»¹ÜÓÐÖ¤¾ÝÅú×¢£¬£¬Î¬³Ö25(OH)DŨ¶ÈÔÚ40ÖÁ80ng/mL¹æÄ£ÄÚ¶Ô¿µ½¡ºÍ¼²²¡Ô¤·À×îΪÀíÏ룬£¬µ«Ðí¶àÕþ¸®ºÍ¿µ½¡»ú¹¹µÄÍÆ¼öÁ¿ÈÔȻƫµÍ£¬£¬Î´Äܳä·ÖʹÓÃάÉúËØDÔÚÔö½ø¿µ½¡·½ÃæµÄDZÁ¦¡£Òò´Ë£¬£¬ÖØÐÂÆÀ¹ÀºÍ¸üÐÂάÉúËØDµÄÍÆ¼öÉãÈëÁ¿¹ØÓÚ¸ÄÉÆÈ«ÇòÉú³ÝµÄ¿µ½¡×´Ì¬ÖÁ¹ØÖ÷Òª¡£Í¨¹ýÌá¸ßѪÇå25(OH)Dˮƽ£¬£¬²»µ«¿ÉÒÔÔöÇ¿¹Ç÷À¿µ½¡£¬£¬»¹¿ÉÒÔ½µµÍ¶àÖÖÂýÐÔ¼²²¡ºÍ¼±ÐÔѬȾµÄ·çÏÕ£¬£¬´Ó¶øÌá¸ßÉúÑÄÖÊÁ¿²¢ïÔÌ­Ò½ÁƱ£½¡±¾Ç®¡£

2. Î¬ÉúËØDµÄºÏ³É


  άÉúËØDµÄºÏ³ÉÊÇά³ÖÈËÌ念½¡µÄÒªº¦Àú³Ì¡£Ö»¹Ü¿ÉÒÔͨ¹ýʳÎïºÍÔö²¹¼ÁÉãȡάÉúËØD£¬£¬µ«´ó²¿·ÖάÉúËØDµÄȪԴÊÇͨ¹ýƤ·ô̻¶ÓÚÑô¹âÖеÄ×ÏÍâÏßB£¨UVB£©À´ºÏ³ÉµÄ¡£Æ¤·ôÖеÄ7-ÍÑÇ⵨¹Ì´¼£¨7-DHC£©ÔÚUVBÕÕÉäÏÂת»¯ÎªÇ°Î¬ÉúËØD3£¬£¬½ø¶øÍ¨¹ýÈÈÒì¹¹»¯ÐγÉάÉúËØD3¡£Õâ¸öÀú³ÌµÄЧÂÊÊܵ½¶àÖÖÒòËØµÄÓ°Ï죬£¬°üÀ¨Æ¤·ôÉ«ËØº¬Á¿¡¢¡¢UVBµÄÇ¿¶ÈºÍ³ÖÐøÊ±¼ä¡¢¡¢Ò»ÌìÖеÄʱ¼ä¡¢¡¢¼¾½Ú¡¢¡¢Ê¹ÓõķÀɹ²úÆ·»òÒÂÎïÒÔ¼°Æ¤·ô״̬µÈ¡£


  άÉúËØD3ÔÚÌåÄÚ¾­ÓÉһϵÁдúлÀú³Ì£¬£¬×îÖÕת»¯ÎªÆä»îÐÔÐÎʽ¡ª¡ª¸Æ»¯Èý´¼£¨1,25(OH)2D£©¡£Ê×ÏÈ£¬£¬Î¬ÉúËØD3ÔÚ¸ÎÔàÖо­ÓÉ25-ôÇ»¯Ã¸µÄ×÷ÓÃת»¯Îª25-ôÇ»ùάÉúËØD£¨25(OH)D£©£¬£¬ÕâÊÇάÉúËØD״̬µÄ×î¼ÑÉúÎï±ê¼ÇÎï¡£Ëæºó£¬£¬25(OH)DÔÚÉöÔàÖеÄ1¦Á-ôÇ»¯Ã¸×÷ÓÃϽøÒ»²½×ª»¯Îª1,25(OH)2D£¬£¬Ò²³ÆÎª¸Æ»¯Èý´¼¡£±ðµÄ£¬£¬Ä³Ð©ÍâÖÜϸ°û£¬£¬ÈçÃâÒßϸ°û£¬£¬Ò²ÄÜͨÏ꾡°ûÄÚµÄ1¦Á-ôÇ»¯Ã¸½«25(OH)Dת»¯Îª1,25(OH)2D£¬£¬Õâ¹ØÓÚËüÃǵı£»£»£»¤ÐÔÐÄÀí×÷ÓÃÖÁ¹ØÖ÷Òª¡£


  ÖµµÃ×¢ÖØµÄÊÇ£¬£¬Æ¤·ôºÏ³ÉάÉúËØDµÄÄÜÁ¦¾ßÓÐÄÚÔڵķ´À¡»úÖÆ£¬£¬¿ÉÒÔ·ÀÖ¹Òò¹ý¹ý»îɹ¶øµ¼ÖÂѪҺÖÐάÉúËØD¹ýÁ¿£¬£¬´Ó¶ø×èֹάÉúËØDÖж¾»ò¸ß¸ÆÑªÖ¢¡£È»¶ø£¬£¬ÕâÖֺϳÉÀú³ÌÔÚÔ糿ºÍ»Æ»è¡¢¡¢¶¬¼¾¡¢¡¢Í¨¹ýË«²ã²£Á§´°µÄÊÒÄÚÈÕɹ£¬£¬»òµ±Æ¤·ô±»ÒÂÎï»ò·Àɹ˪ÁýÕÖʱÏÕЩ²»»á±¬·¢¡£Òò´Ë£¬£¬ÉúÑÄÔÚ¸ßγ¶ÈµØÇø»òÒòÎÄ»¯Ï°¹ß×èÖ¹ÈÕɹµÄÈËÃÇÍùÍùÃæÁÙάÉúËØDȱ·¦µÄ·çÏÕ£¬£¬Õâ¾ÍÐèҪͨ¹ýÒûʳ¡¢¡¢Ôö²¹¼Á»òÇå¾²µÄÈÕ¹âÔ¡À´È·±£×ã¹»µÄάÉúËØDˮƽ¡£


3. Î¬ÉúËØDµÄÐÄÀí×÷ÓÃÓ뿵½¡Ö÷ÒªÐÔ


  άÉúËØDµÄÐÄÀíѧÊÇÒ»ÃÅÑо¿Î¬ÉúËØDÔÚÈËÌåÖÐ×÷ÓõĿÆÑ§¡£ÕâÖÖÖ÷ÒªµÄÓªÑøËØÔÚÌåÄÚÊÎÑÝ×ŶàÖÖ½ÇÉ«£¬£¬ÆäÐÄÀí¹¦Ð§²»µ«ÏÞÓÚÖ§³Ö¹Ç÷À¿µ½¡£¬£¬»¹À©Õ¹µ½µ÷ÀíÃâÒßϵͳ¡¢¡¢Ó°Ïìϸ°ûÉú³¤ºÍ·Ö»¯£¬£¬ÒÔ¼°Î¬³ÖÕûÌ念½¡¡£


  ¸Æ»¯Èý´¼£¬£¬ÊÇͨ¹ýһϵÁдúл·½·¨ÔÚÌåÄÚÌìÉúµÄ¡£Õâ¸öÀú³Ì×îÏÈÓÚÆ¤·ô̻¶ÓÚ×ÏÍâÏßB£¨UVB£©Ï£¬£¬½«7-ÍÑÇ⵨¹Ì´¼£¨7-DHC£©×ª»¯ÎªÎ¬ÉúËØD3¡£Ëæºó£¬£¬Î¬ÉúËØD3ÔÚ¸ÎÔàÖб»×ª»¯Îª25-ôÇ»ùάÉúËØD£¨25(OH)D£©£¬£¬²¢ÔÚÉöÔàÖнøÒ»²½×ª»¯Îª1,25(OH)2D¡£ÖµµÃ×¢ÖØµÄÊÇ£¬£¬1,25(OH)2D²»µ«ÔÚÉöÔàÖб¬·¢£¬£¬Ä³Ð©ÍâÖÜϸ°û£¬£¬ÈçÃâÒßϸ°ûºÍÉÏÆ¤Ï¸°û£¬£¬Ò²ÄÜÆ¾Ö¤¾Ö²¿ÐèÒªºÏ³ÉÕâÖÖ¼¤ËØ¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvMTExOTI3OTY5N2FlMzdiYmFkYTIyOGQ0MjNiNDg1MzkucG5n
7-ÍÑÇ⵨¹Ì´¼(7-DHC)ÔÚ̻¶ÓÚUVBÉäÏߺóÌìÉúάÉúËØD3µÄ;¾¶


  άÉúËØDÔÚµ÷Àí¸ÆºÍÁ×´úлÖÐÆð×ÅÖÁ¹ØÖ÷ÒªµÄ×÷Óá£Ëüͨ¹ýÔö½ø³¦µÀ¶Ô¸ÆºÍÁ×µÄÎüÊÕ¡¢¡¢µ÷ÀíÉöÔà¶ÔÕâЩ¿óÎïÖʵÄÖØÎüÊÕ£¬£¬ÒÔ¼°Î¬³Ö¹Ç÷À¿ó»¯£¬£¬À´¼á³ÖѪҺÖиƺÍÁ×µÄŨ¶ÈÎȹÌ¡£±ðµÄ£¬£¬Î¬ÉúËØD»¹¼ÓÈëµ÷Àí¼××´ÅÔÏÙ¼¤ËØ£¨PTH£©µÄÉøÍ¸£¬£¬ÕâÊÇÒ»ÖÖµ÷ÀíѪ¸ÆË®Æ½µÄÒªº¦¼¤ËØ¡£


  ³ýÁËÕâЩ¾­µä¹¦Ð§Í⣬£¬Î¬ÉúËØD»¹¾ßÓÐÆÕ±éµÄ·Ç¹Ç÷ÀЧӦ¡£ÀýÈ磬£¬Ëüͨ¹ýÓëάÉúËØDÊÜÌ壨VDR£©Á¬Ïµ£¬£¬Ó°Ïì»ùÒò±í´ï£¬£¬´Ó¶øµ÷ÀíÃâÒßϸ°ûµÄ¹¦Ð§¡£ÕâÖÖµ÷Àí×÷ÓÃÓÐÖúÓÚÔ¤·ÀijЩ×ÔÉíÃâÒß¼²²¡ºÍijЩÀàÐ͵ݩ֢¡£±ðµÄ£¬£¬Î¬ÉúËØD»¹¼ÓÈëµ÷Àíϸ°ûÔöÖ³¡¢¡¢·Ö»¯ºÍµòÍö£¬£¬Ó°Ï켡È⹦Ч£¬£¬ÉõÖÁÓ°ÏìÐÄÀí¿µ½¡£¬£¬°üÀ¨ÇéÐ÷ºÍÈÏÖª¹¦Ð§¡£


  άÉúËØDµÄÐÄÀí×÷ÓÃÇ¿µ÷ÁËά³ÖÊʵ±ÑªÇå25(OH)DˮƽµÄÖ÷ÒªÐÔ¡£Ñо¿Åú×¢£¬£¬µÍÓÚ40ng/mLµÄˮƽÓë¶àÖÖ¿µ½¡ÎÊÌâÏà¹Ø£¬£¬¶ø½«25(OH)DŨ¶Èά³ÖÔÚ40ÖÁ80ng/mL¹æÄ£ÄÚ¿ÉÄÜÓÐÖúÓÚÔ¤·À¶àÖÖÂýÐÔ¼²²¡¡£Òò´Ë£¬£¬È·±£×ã¹»µÄάÉúËØDÉãÈë¹ØÓÚά»¤ÕûÌ念½¡ÖÁ¹ØÖ÷Òª¡£


  È»¶ø£¬£¬ÓÉÓÚµØÀíλÖᢡ¢¼¾½Ú¡¢¡¢Æ¤·ôÉ«ËØ¡¢¡¢·ÀɹÐÐΪµÈÒòËØ£¬£¬Ðí¶àÈË¿ÉÄÜÎÞ·¨Í¨¹ýÈÕɹ»ñµÃ×ã¹»µÄάÉúËØD¡£Òò´Ë£¬£¬ÒûʳºÍÔö²¹¼Á³ÉΪÖ÷ÒªµÄάÉúËØDȪԴ¡£Ê³ÎïȪԴ°üÀ¨ÓÍÐÔÓãÀà¡¢¡¢Ç¿»¯Ê³ÎïºÍijЩ̹½£¬£¬µ«ÕâЩȪԴ¿ÉÄÜÎÞ·¨Ìṩ×ã¹»µÄάÉúËØD£¬£¬ÌØÊâÊǹØÓÚÓÐÌØ¶¨ÐèÇóµÄÈËȺ£¬£¬ÈçÍíÄêÈË¡¢¡¢Ôи¾ºÍµØÀíλÖÃÔ¶Àë³àµÀµÄÈËȺ¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvNGNiZWUyNWZjMDI3YzQyMDNmMTJiMGFjMWNkZDU5YmUucG5n
άÉúËØ D£¨1,25(OH) 2 D£©µÄ¸üÆÕ±é¹¦Ð§£º£º£º¸Ãͼ˵Ã÷ÎúÓ°ÏìÉíÌåÖÖÖÖϸ°ûºÍ×éÖ¯µÄÄÚÉøÍ¸ºÍ·ÇÄÚÉøÍ¸¹¦Ð§

1. Î¬³ÖÐÄÀíѪÇå25(OH)DŨ¶ÈµÄ±¾Ç®


  άÉúËØDµÄ¿µ½¡¾­¼Ãѧǿµ÷ÁËά³ÖÊʵ±ÑªÇå25(OH)DŨ¶ÈµÄ±¾Ç®Ð§Ò档άÉúËØD×÷ΪһÖÖÆÕ±é¿ÉÓõÄ΢Á¿ÓªÑøËØ£¬£¬ÆäÔö²¹³ÉÄÚÇé¶Ô½ÏµÍ£¬£¬ÓÈÆäÓëÖÎÁÆÎ¬ÉúËØDȱ·¦Ïà¹Ø¼²²¡£¨ÈçÐÄѪ¹Ü¼²²¡¡¢¡¢×ÔÉíÃâÒß¼²²¡¡¢¡¢Ä³Ð©°©Ö¢£©µÄ¸ß°ºÒ½ÁÆÓöÈÏà±È¡£ÀýÈ磬£¬Î¬ÉúËØD3Ôö²¹¼ÁÔÚÎ÷·½Êг¡ÉϵÄÄ깩Ӧ±¾Ç®Í¨³£²»µ½8ÃÀÔª£¬£¬¶øÕë¶ÔάÉúËØDȱ·¦Ö¢µÄÖÎÁƺÍÏà¹Ø²¢·¢Ö¢µÄ´¦ÀíÓöȿÉÄÜÿÄê¸ß´ïÊýǧÖÁÊýÍòÃÀÔª¡£

  ͨ¹ý¿Ú·þάÉúËØDÔö²¹¼Á»òͨ¹ýÇå¾²µÄÈÕɹÀ´Î¬³ÖѪÇå25(OH)DˮƽÔÚ40ÖÁ80ng/mLµÄ¹æÄ£ÄÚ£¬£¬¿ÉÒÔÏÔÖø½µµÍijЩÂýÐÔ¼²²¡µÄ·¢²¡ÂʺÍéæÃüÂÊ£¬£¬´Ó¶øïÔÌ­ºã¾ÃÒ½ÁÆÓöÈ¡£±ðµÄ£¬£¬Í¨¹ýÔ¤·À¼²²¡£¬£¬Î¬ÉúËØDÔö²¹»¹¿ÉÄÜÌá¸ß¸öÌåµÄÉúÑÄÖÊÁ¿ºÍÊÂÇéÉú²úÁ¦¡£

  ¹«¹²ÎÀÉúÕ½ÂÔ£¬£¬ÈçÃãÀøÑô¹âÕÕÉä¡¢¡¢Ê³ÎïÇ¿»¯ºÍάÉúËØDÔö²¹Ö¸µ¼£¬£¬¿ÉÒÔ×÷Ϊ±¾Ç®Ð§Òæ¸ßµÄÊÖ¶ÎÀ´Ìá¸ßÈËȺµÄάÉúËØDˮƽ¡£ÕâЩսÂÔµÄʵÑ鱾ǮԶµÍÓÚÖÎÁÆÎ¬ÉúËØDȱ·¦ÒýÆðµÄ¿µ½¡ÎÊÌâµÄÆÆ·Ñ¡£Òò´Ë£¬£¬Í¶×ÊÓÚÔ¤·À²½·¥²»µ«ÓÐÖúÓÚÌá¸ß¹«¹²¿µ½¡Ë®Æ½£¬£¬»¹¿ÉÄÜÔÚ¾­¼ÃÉÏ´øÀ´½ÚÔ¼¡£

2. ×ܽáÓëÕ¹Íû


  άÉúËØD×÷ΪҪº¦µÄ΢Á¿ÓªÑøËØ£¬£¬¶Ôά»¤¹Ç÷À¿µ½¡¡¢¡¢ÃâÒßϵͳµ÷ÀíÒÔ¼°Ô¤·À¶àÖÖÂýÐÔ¼²²¡ÖÁ¹ØÖ÷Òª¡£Ä¿½ñÈ«ÇòÆÕ±é±£´æÎ¬ÉúËØDȱ·¦ÎÊÌ⣬£¬ÓÈÆäÊÇÔÚ¸ßγ¶ÈµØÇøºÍ×èÖ¹ÈÕɹµÄÈËȺÖС£Î¬³Ö25(OH)DˮƽÔÚ40ÖÁ80ng/mL¹æÄ£ÄÚ£¬£¬²»µ«Äܹ»ÔöÇ¿¹Ç÷À¿µ½¡£¬£¬»¹ÄܽµµÍÂýÐÔ¼²²¡·çÏÕ£¬£¬Ìá¸ßÉúÑÄÖÊÁ¿¡£

  δÀ´£¬£¬Í¨¹ýÌá¸ß¹«ÖÚ¶ÔάÉúËØDÖ÷ÒªÐÔµÄÊìϤ£¬£¬ÃãÀøÇå¾²ÈÕɹ¡¢¡¢ÔöÌíÒûʳÉãÈëºÍÊʵ±Ôö²¹£¬£¬ÓÐÍû¸ÄÉÆÈ«ÇòÉú³ÝµÄάÉúËØD״̬£¬£¬ïÔÌ­Ïà¹Ø¼²²¡µÄÒ½ÁƼ縺£¬£¬ÊµÏÖ¸üÆÕ±éµÄ¿µ½¡ºÍ¾­¼ÃÐ§Òæ¡£

  ²Î¿¼ÎÄÏ×
1.Wimalawansa SJ. Physiology of Vitamin D-Focusing on Disease Prevention. Nutrients. 2024;16(11). doi:10.3390/nu16111666

·ÖÏíµ½£º£º£º

ÔĶÁ¸ü¶àÎÄÕÂ
READ MORE

]]>
/?feed=rss2&p=40304 0
w66À´Àû¹ú¼ÊЯÊÖÊ¥·å»Û ¿ªÆôÈ«ÐÂÔ˶¯ÓªÑøµÝËÍ·½Ê½ /?p=40285 /?p=40285#comments Mon, 11 Aug 2025 06:51:32 +0000 http://www.jialanhai.com/?p=40285

ÉÅʳGABAµÄÉñÃØÊµÁ¦£º£º£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³×

2025-09-30 14:06


7ÔÂ30ÈÕÉÏÎ磬£¬w66À´Àû¹ú¼ÊÊ×´´ÈËËÎåªöª¡¢¡¢ÁªºÏÊ×´´ÈËËïÈʺÆÒ»Ðе½·Ãº¼ÖÝÊ¥·å»ÛÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾£¬£¬»ñÊ¥·å»ÛÁªºÏÊ×´´ÈË¡¢¡¢Á½½ì°ÂÔËÌøÂí¹Ú¾üÂ¥ÔÆ¼°Õã½­Ê¡¹ãÎ÷É̻ᴴ»á»á³¤ÑîÒãµÄÈÈÇé½Ó´ý¡£Ë«·½ÉîÈë̽ÌÖÔ˶¯´ó¿µ½¡ÁìÓòµÄÊÖÒÕÁ¢ÒìÓ빤ҵÈںϣ¬£¬¸æ¿¢Ô˶¯ÄÜÁ¿ÄÉÃ×ÅçÎíÏîÄ¿µÄÏàÖú¹²Ê¶£¬£¬ÎªÐÐÒµÊÖÒÕÉý¼¶Óë²úÆ·Ë¢ÐÂ×¢ÈëÇ¿¾¢¶¯ÄÜ¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvOTNiODZlNWNiYzJiOTUwMWE0OWU2ZmJhNGUzZjU3NzQuanBn
¿ªÆôÓªÑøÔö²¹ÐÂʱ´ú

w66À´Àû¹ú¼ÊÊÇÈ«ÇòÄÉÃ×ÊÖÒÕÓ¦ÓÃÁìÓòµÄÁì¾üÆóÒµ£¬£¬ÓµÓÐÃÀ¹úרÀûÉ̱ê¾ÖÊÚȨµÄÊ×Ïî¿ÉÓÃÓÚÈËÌåµÄÄÉÃ×ÊÖÒÕרÀû¡£¹«Ë¾´î½¨µÄÈ«ÐÂÄÉÃ×ÓªÑøËØµÝËÍÆ½Ì¨£¬£¬½â¾öÁ˹Űå¼ÁÐÍÎüÊÕºÍÍÌÑÊ·½ÃæµÄÀ§ÈÅ£¬£¬¾ßÓгä·ÖÎüÊÕ¡¢¡¢Çå¾²ÎȹÌ¡¢¡¢Ê¹Óñã½ÝµÈÖî¶àÓÅÊÆ£¬£¬ÓÐÓõØÌáÉýÁËÓªÑøËØµÄÎüÊÕЧÂÊÓëÉúÎïʹÓöÈ¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvYzA2YmYwYTFhMGJjNzMxOGM0YjhjZDRmZGQ2MzU5MjAuanBn
ÄÉÃ×ÊÖÒÕ¸³ÄÜÔ˶¯¿µ½¡

º¼ÖÝÊ¥·å»ÛÒÔ¡°¿Æ¼¼¸³ÄÜÔ˶¯¿µ½¡¡±Îª½¹µã¶¨Î»£¬£¬ÔÚÊ×´´ÈËÍŶÓÒýÁìÏÂÕ¹ÏÖÆæÒìÐÐÒµÓÅÊÆ¡£´Ë´Î¿¼²ìÖ¼ÔÚ´î½¨Ç°ÑØÊÖÒÕÓëÔ˶¯¿µ½¡ÐèÇóµÄ¶Ô½ÓÇÅÁº¡£½«´ó·Ö×ÓµÄÓªÑøÎïÖÊÖÆ±¸³ÉÄÉÃ×¼¶Ð¡·Ö×ÓÒºÌ壬£¬Í¨¹ý¶¨Á¿µÄ¹ã½ÇÅçÎí×°Ö㬣¬¾­¿ÚÇ»ð¤Ä¤ÎüÊÕÖ±½Ó½øÈëÈËÌåÑ­»·£¬£¬ÎªÔ˶¯³¡¾°¼´Ê±ÓªÑøÔö²¹Ìṩ¸ïÃüÐÔ¿ÉÄÜ¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvYjA4ODVjY2EwNTJmMWI2MGU0ZGQ5NzNiNGRhZjY4MjEuanBn
ǿǿÁªÊÖ ¹²ÖþÔ˶¯´ó¿µ½¡ÐÂÉú̬

º¼ÖÝÊ¥·å»ÛµÄÊг¡µ÷ÑÐÏÔʾ£¬£¬80%µÄÔ˶¯Ï²»¶ÕßÒÔΪ¡°Ô˶¯Öеļ´Ê±ÓªÑøÔö²¹·½Ê½Î´±ã¡±£¬£¬65%µÄרҵÔË·¢¶¯µ£ÐÄ¡°½ºÄÒ¡¢¡¢Æ¬¼ÁµÈ¹Å°åÔö²¹¼ÁÓг¦Î¸´úл¸ºµ£¡£¡±¡£w66À´Àû¹ú¼ÊÄÉÃ×ÊÖÒÕ½«È«ÐÂÓªÑøËØµÝËÍ·½Ê½´Ó¡°ÊµÑéÊÒ¡±ÍÆÏò¡°Èü³¡¡±£¬£¬Ö÷´ò¡°30ÃëÆðЧ¡¢¡¢ÎÞ³¦Î¸¸ºµ£¡£¡±£¬£¬Ìî²¹º£ÄÚÔ˶¯ÓªÑøËØÅçÎíµÄÊг¡¿Õȱ¡£

¾ÝϤ£¬£¬Ë«·½ÍýÏëÈý¸öÔÂÄÚÍê³ÉÊ×Åú²úÆ·Åä·½µ÷ÊÔÓëСÊÔÉú²ú£¬£¬Ô¤¼ÆÄêµ×ÍÆ³öÊ׿îÁªÃû²úÆ·¡ª¡ªÔ˶¯ÄÜÁ¿ÄÉÃ×ÅçÎí¡£´Ë´ÎÏàÖúÉî¶ÈÈÚºÏÁËÄÉÃ×ÊÖÒÕÓëÓªÑø¼´Ê±Ôö²¹³¡¾°£¬£¬¿ª´´ÐÐҵбê¸Ë£¬£¬Îª¹«¹²¿ÆÑ§Ô˶¯¡¢¡¢¸ßÐ§ÓªÑøÔö²¹Ìṩǿʢ¿Æ¼¼Ö§³Ö¡£


·ÖÏíµ½£º£º£º

ÔĶÁ¸ü¶àÎÄÕÂ
READ MORE

]]>
/?feed=rss2&p=40304 0
Äϲý´óѧÑо¿·¢Ã÷£º£º£ºÈé¼Á¿ÉÄÜÓÐÖúÓÚÌá¸ßÓªÑøËØÎüÊÕÖúÁ¦¿µ½¡ /?p=40230 /?p=40230#comments Thu, 31 Jul 2025 03:56:00 +0000 http://www.jialanhai.com/?p=40230

Äϲý´óѧÑо¿·¢Ã÷£º£º£ºÈé¼Á¿ÉÄÜÓÐÖúÓÚÌá¸ßÓªÑøËØÎüÊÕÖúÁ¦¿µ½¡


  ¿ËÈÕ£¬£¬Äϲý´óѧÐû²¼ÁËһƪеÄÓªÑø±£½¡Æ·Èé¼ÁÉúÎïʹÓöȵÄÑо¿Ï£Íû£¬£¬¸ÃÑо¿ÉîÈë̽ÌÖÁËÓªÑøËØÈé¼ÁÔÚ¿Ú·þºóÔÚ賦µÀµÄת»¯Àú³Ì[1]¡£Õ¹ÏÖÁËÈé¼ÁÔÚ¿Ú·þºóÔÚ賦µÀµÄ´¦ÀíÀú³Ì¶ÔÓªÑøÎïÖÊÉúÎïʹÓöȵÄÒªº¦Ó°Ï죬£¬Ç¿µ÷ÁËÓÅ»¯Èé¼ÁÎïÀí»¯Ñ§ÐÔ×ÓºÍÈ·±£ÆäÇå¾²ÐÔµÄÖ÷ÒªÐÔ¡£


1.¿Ú·þÓªÑøÈéÒºµÄÏû»¯Àú³Ì

  µ±ÒºÌ¬O/WÈé¼Á½øÈë¿Úǻʱ£¬£¬ËüÃÇÓëÍÙÒº»ìÏý£¬£¬×îÏÈÆðÔ´µÄÏû»¯Àú³Ì¡£ÍÙÒºÖеÄα-µí·Ûø×îÏȾÙÐеí·ÛµÄË®½â×÷Ó㬣¬½«Ê³ÎïÖеĿÉÏû»¯µí·Û²¿·Öת»¯ÎªÌÇ¡£±ðµÄ£¬£¬¿ÚÇ»ð¤Ä¤Ò²¿ÉÄÜÊÇijЩÉúÎï»îÐÔ·Ö×Ó£¨ÈçάÉúËØB12¡¢¡¢½ª»ÆËغͰ×޼«´¼£©µÄÎüÊÕ²¿Î»¡£ÔÚ¿ÚÇ»ÖУ¬£¬Èé¼Á¿ÉÄÜ»áÂÄÀúһϵÁеÄÎïÀíת±ä£¬£¬ÈçÒºµÎµÄÄý¾ÛºÍºÏ²¢¡£ÕâЩ¸Ð¹ÙÌåÑ鹨ÓÚʳÎïºÍÒûÁϲúÆ·µÄ¿Ú¸ÐºÍ½ÓÊܶÈÖÁ¹ØÖ÷Òª¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDcvNzRhZmU1Y2IwNGRjNjA4YTQ3NThjZWQzZjk1MTM1OTcucG5n

Èé¼ÁÔÚ賦µÀÏû»¯Àú³ÌÖпÉÄܱ¬·¢µÄÎïÀí»¯Ñ§ºÍÉúÎﻯѧת±äʾÒâͼ[2]


2.ÓªÑøËØÈé¼ÁÔÚθ²¿Ïû»¯Àú³Ì

  Èé¼ÁÔÚ¾­ÓÉ¿ÚÇ»ºó£¬£¬½øÈëθ²¿×îÏÈÊܵ½Î¸µÄÏû»¯ÇéÐεÄÓ°Ï졣θΪһ¸öËáÐÔÇéÐΣ¬£¬ÆäÖеÄθËáºÍÏû»¯Ã¸»áÓëÈé¼ÁÖеÄÒòËØ»¥¶¯¡£ÕâÖÖ»¥¶¯¿ÉÄܵ¼ÖÂÈé¼ÁÖеÄÒºµÎ±¬·¢Äý¾Û¡¢¡¢ºÏ²¢»òÆäËûÎïÀíת±ä¡£Î¸ÖеÄÏû»¯Ã¸£¬£¬ÈçθÂѰ×ø£¬£¬»á×îÏÈÆÊÎöÈé¼ÁÖеÄÂѰ×ÖÊ¡¢¡¢Ö¬·¾ºÍÆäËû´ó·Ö×Ó¡£ÕâÒ»Àú³Ì¾öÒéÁËÓªÑøËØµÄÊÍ·ÅËÙÂʺͷ½Ê½¡£


3.ÓªÑøËØÈé¼ÁÔÚС³¦Ïû»¯Àú³Ì

  ÈËÀàµÄС³¦º¬ÓÐÄܹ»Ïû»¯Èé¼ÁÖÐÖÖÖÖ´ó·Ö×ÓµÄÖØ´óø»ìÏýÎС³¦Òº°üÀ¨µ¨ÑΣ¨Ò»ÖÖÉúÎïÍâò»îÐÔ¼Á£©¡¢¡¢µç½âÖʺͶàÖÖÏû»¯Ã¸£¬£¬ÒÔÔö½øÏû»¯ºÍÎüÊÕÀú³Ì¡£ÒÈÏٵĵí·Ûø¡¢¡¢ÂѰ×øºÍÖ¬·¾Ã¸»áË®½âÈé¼ÁÖб£´æµÄÖÖÖÖµí·Û¡¢¡¢ÂѰ×ÖʺÍÖ¬·¾¡£ÕâЩ×é·Ö¿ÉÄÜÊÇÈé¼ÁÖеÄ£¬£¬Ò²¿ÉÄÜÊÇÓÉʳÎïÖÐÆäËûÒòËØÐγɵÄ¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDcvYjFkNzVkMDI0MjViNjg0ZDc2MDU5ODc4MDdlNWEwNWUucG5n

Ë®°üÓÍÈé¼ÁÔÚС³¦Ïû»¯Àú³ÌÖиÄÉÆÇ×Ö¬ÐÔÓªÑø±£½¡Æ·ÉúÎï¿É¼°ÐÔµÄDZÔÚ»úÖÆ


4.ÓªÑøËØµÄ½ºÊø»¯

  ½ºÊø»¯ÊÇÒ»¸öÉæ¼°»ìÏý½ºÊø£¨°üÀ¨½ºÊøºÍÄÒÅÝ£©ÐγɵÄÀú³Ì£¬£¬ËüÓÐÖúÓÚÖ¬½â²úÆ·ºÍÆäËûÇ×Ö¬·Ö×Ó£¬£¬ÈçÇ×Ö¬ÓªÑøËØµÄÁ¬Ïµ¡£ÕâÖÖÁ¬ÏµÄÜÁ¦ºÜ´ó³Ì¶ÈÉÏÈ¡¾öÓÚ»ìÏý½ºÊøÄÚ²¿ÐγɵÄÊèË®ÇøÓòµÄ¾Þϸ£¬£¬¶øÕâ¸ö¾ÞϸÓÖÓëÓÍÏàÖÐÖ¬·¾ËáµÄÁ´³¤ÓйØ¡£Ëæ×ÅÁ´³¤µÄÔöÌí£¬£¬ÊèË®ÇøÓòµÄ¾ÞϸҲ»áÔöÌí£¬£¬ÕâÒâζ×ų¤Á´Ö¬·¾Ëá¿ÉÄÜÐγɸü´óµÄÊèË®ÇøÓò£¬£¬´Ó¶ø¸üÈÝÒ×Á¬ÏµºÍЯ´ø¸ü¶àµÄÇ×Ö¬ÓªÑøËØ¡£½ºÊø»¯ÔÚÓªÑøËØµÄÎüÊÕÖÐÆðµ½Òªº¦×÷Ó㬣¬ÓÉÓÚËüʹµÃÇ×Ö¬ÓªÑøËØ´ÓʳÎïÖÐÊͷŲ¢±»°ü¹üÔÚ½ºÊøÖУ¬£¬½ø¶ø¸üÈÝÒ×±»Ð¡³¦ÉÏÆ¤Ï¸°ûµÄĤÎüÊÕ¡£


5.ÓªÑøËØµÄ´úлºÍÎüÊÕ

  ÓªÑøËØ£¬£¬ÈçÖ¬ÈÜÐÔάÉúËØ¡¢¡¢ÀàºúÂܲ·ËغͶà·Ó£¬£¬Í¨¹ý±»¶¯À©É¢»òÔØÌå½éµ¼µÄ»úÖÆ±»ÎüÊÕ¡£ÕâÐ©ÓªÑøËØÔÚ½øÈëС³¦ÉÏÆ¤Ï¸°ûºó¿ÉÄÜ»áÂÄÀúһϵÁеĴúлÀú³Ì£¬£¬ÆäÖÐÒ»Ð©ÓªÑøËØºÍËüÃǵĴúлÎï¿ÉÄÜ»áͨ¹ýÌØ¶¨µÄתÔËÂѰף¨ÀýÈçP-gp, MRP2, BCRPµÈ£©±»ÔËÊ仨µ½³¦Ç»ÖС£
ÓªÑøËØ·Ö×Óͨ¹ýС³¦Ãž²Âö±»ÎüÊպ󣬣¬Ê×ÏÈÔÚ¸ÎÔྭÓÉÊ×¹ýЧӦ¡£ÔÚÕâ¸öÀú³ÌÖУ¬£¬ÓªÑøËØ¿ÉÄÜ»áÂÄÀúһϵÁеĻ¯Ñ§×ª»¯£¬£¬ÕâÊÇÓɸÎÔàµÄPhase IºÍIIøÍê³ÉµÄ¡£ÕâÒ»´úлÀú³Ì¹ØÓÚijЩÉãÈëÎïÖʵĽⶾºÜÊÇÖ÷Òª£¬£¬ÓÉÓÚËü¿ÉÒÔÒÖÖÆÎüÊÕ¡¢¡¢Ôö½øÉøÍ¸£¬£¬²¢ïÔÌ­ÉúÎï»îÐÔ¡£
ԼĪ90%µÄ³¤Á´Ö¬·¾ËáºÍÉÙÁ¿µÄÖÐÁ´Ö¬·¾ËáÔÚÉÏÆ¤Ï¸°ûÖб»×é×°³ÉTAGs£¬£¬È»ºóÐγɵ¨¹Ì´¼Î¢Á£µÄÊèË®ºË£¬£¬ÕâЩ΢Á£±»Êͷŵ½³¦ÁܰÍÖС£ÕâÒ»Àú³ÌÉæ¼°ÄÚÖÊÍøºÍ¸ß¶û»ùÌåÖ®¼äµÄЭ×÷£¬£¬²¢Éæ¼°µ½ÖîÈçÔØÖ¬ÂѰ×B48£¨apoB48£©¡¢¡¢ÔØÖ¬ÂѰ×AI£¨apoAI£©µÈµÄÖ¬ÂѰס£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDcvYzhiNDNhZGUyODBiYTgwNzVjNDI5NGE5MmU4ZTAxNzQucG5n

ÉãÈ¡ºÍʹÓÃÇ×Ö¬ÐÔÓªÑø±£½¡Æ·µÄ¿ÉÄÜÐÔ;¾¶


  ×ܽá

  ÓªÑøÈé¼ÁÔÚ¿Ú·þºóÔÚ賦µÀµÄ´¦ÀíÀú³Ì¹ØÓÚÃ÷È·ÓªÑøÎïÖʵÄÉúÎïʹÓöȾßÓÐÖ÷ÒªÒâÒå¡£Èé¼ÁÔÚ¿ÚÇ»µÄ¶ÌÔÝÍ£ÁôÓëÆäÔÚС³¦µÄÏû»¯ºÍÎüÊÕÀú³ÌÇ×½üÏà¹Ø¡£Èé¼ÁÔÚθºÍС³¦ÖеÄÏû»¯ÇéÐΡ¢¡¢ÎïÀí»¯Ñ§×ª±ä¡¢¡¢ÒÔ¼°ÓëÏû»¯Ã¸µÄ»¥¶¯¶¼Ó°ÏìÁËÓªÑøËØµÄÊͷźÍÎüÊÕ¡£½ºÊø»¯Àú³Ì½øÒ»²½Ôö½øÁËÇ×Ö¬ÓªÑøËØµÄÁ¬ÏµºÍÊÍ·Å£¬£¬¶øÓªÑøËصĴúлºÍÎüÊÕÉæ¼°ÁËС³¦ºÍ¸ÎÔàµÄ¶à¸öÖØ´óÀú³Ì¡£

Ëæ×ÅÄÉÃ×ÊÖÒÕºÍÉúÎïÊÖÒÕµÄǰ½ø£¬£¬Èé¼ÁÖÆ±¸ÊÖÒÕÕý³¯ÏòÌá¸ßÓªÑøËØµÄÎȹÌÐÔºÍÉúÎïʹÓöȿªÕ¹¡£ÓÅ»¯Èé¼ÁµÄÎïÀí»¯Ñ§ÐÔ×Ó£¬£¬ÈçÒºµÎ¾ÞϸºÍÈ黯¼ÁÀàÐÍ£¬£¬ÊÇÌá¸ßÉúÎïʹÓöȵÄÒªº¦¡£Í¬Ê±£¬£¬È·±£ÓªÑøÈé¼ÁµÄÇå¾²ÐÔ£¬£¬ÌØÊâÊÇÆäºã¾ÃÉãÈëµÄÓ°Ï죬£¬Ò²ÈÕÒæÊܵ½ÖØÊÓ¡£


  ²Î¿¼ÎÄÏ×£º£º£º

[1] X. Chen, Y. Chen, Y. Liu, L. Zou, D. J. McClements, and W. Liu, “A review of recent progress in improving the bioavailability of nutraceutical-loaded emulsions after oral intake,” Compr. Rev. Food Sci. Food Saf., vol. 21, no. 5, pp. 3963–4001, 2022, doi: 10.1111/1541-4337.13017.

[2] A. C. Pinheiro, R. F. S. Gonçalves, D. A. Madalena, and A. A. Vicente, “Towards the understanding of the behavior of bio-based nanostructures during in vitro digestion,” Curr. Opin. Food Sci., vol. 15, pp. 79–86, 2017, doi: https://doi.org/10.1016/j.cofs.2017.06.005.

]]>
/?feed=rss2&p=40230 0
w66À´Àû¹ú¼Ê X ÄÔ´ÎÔª ÏàÖúÐÂÆª ¹²Ó®Î´À´ /?p=40275 /?p=40275#comments Fri, 08 Aug 2025 08:46:48 +0000 http://www.jialanhai.com/?p=40275

ÉÅʳGABAµÄÉñÃØÊµÁ¦£º£º£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³×

2025-09-30 14:06


2025Äê7ÔÂ11ÈÕ£¬£¬w66À´Àû¹ú¼ÊÓëÕã½­ÄÔ´ÎÔª¿Æ¼¼ÓÐÏÞ¹«Ë¾Õ½ÂÔÏàÖúǩԼÒÇʽÔÚÉϺ£IBP¹ú¼Ê¾Û»áÖÐÐľÙÐС£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvMmZiYzM4NWQ3MjVmMGE4MjdhOTRmNjIzZWEzYmU3ZTUuanBn
Ç©ÊðÕ½ÂÔÏàÖúЭÒé

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvYTU2MzBhMmJiZmNmOWFhNjY2NzA3ZWNlNWNiOTdiNzUuanBn
Ðû²¼Ç©Ô¼ÀÖ³É

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvMjkxMjg5YWM4ZGU3MTdkZjY1Nzk1NmFiZWNmNzY1N2YuanBn
½»Á÷ǩԼЭÒé

ÄÔ´ÎÔª½ð×ܼ°ÍŶÓÒ»ÐÐר³Ì¸Ïµ½w66À´Àû¹ú¼ÊÉϺ£×ܲ¿£¬£¬ÂÃÐÐÁËÐÂÆ·Ð§¹ûչʾ¡£w66À´Àû¹ú¼ÊÄÉÃ×ÊÖÒÕËï×ܳöϯǩԼÒÇʽ²¢È«³Ì½Ó´ýÁËÄÔ´ÎÔªÍŶÓ¡£Ë«·½½«ÁªºÏÍÆ¶¯½â¾öѹÁ¦¡¢¡¢½¹ÂÇ¡¢¡¢ÒÖÓô¡¢¡¢Ê§ÃßµÈÇéÐ÷ÖÎÀí²úÆ·µÄÉÏÊС£Î´À´ÒÑÀ´£¬£¬Á¢ÒìǰÐУ¡£¡


·ÖÏíµ½£º£º£º

ÔĶÁ¸ü¶àÎÄÕÂ
READ MORE

]]>
/?feed=rss2&p=40304 0
¡¶Free Radical Research¡·£º£º£ºÍʺÚËØÖúÎÒÃÇ·´¿¹¡°Ñõ»¯Ñ¹Á¦¡±£¡£¡ /?p=40220 /?p=40220#comments Fri, 27 Jun 2025 07:58:00 +0000 http://www.jialanhai.com/?p=40220
¡¶Free Radical Research¡·£º£º£ºÍʺÚËØÖúÎÒÃÇ·´¿¹“Ñõ»¯Ñ¹Á¦”£¡£¡

   ÄãÖªµÀÂ𣬣¬ÍʺÚËØµÄÔö²¹¿ÉÒÔÔöÇ¿ÔË·¢¶¯ÔÚ¸ßÇ¿¶ÈѵÁ·Ê±´úµÄ¿¹Ñõ»¯ÄÜÁ¦£¬£¬²¢ïÔÌ­Ñ×֢״̬¡£

   ½üÆÚ½ÒÏþÔÚFree Radical ResearchÔÓÖ¾ÉϵÄһƪÂÛÎÄ·¢Ã÷£¬£¬ÍʺÚËØÔö²¹µ¼ÖÂÔË·¢¶¯µÄÑõ»¯Ó¦¼¤±ê¼ÇÎïÏÔÖøïÔÌ­£¬£¬²¢ÔöÇ¿ÁË¿¹Ñõ»¯Ã¸µÄ»îÐÔ[1]¡£Êý¾Ý½øÒ»²½ÏÔʾ£¬£¬¸ßÇ¿¶ÈѵÁ·µÄרҵÔË·¢¶¯ÌåÄÚµÄÑõ»¯Ó¦¼¤ºÍÑ×Ö¢Àú³ÌÔöÌí£¬£¬µ«ÍʺÚËØÔö²¹¿ÉÄÜÓÐÖúÓÚ±£»£»£»¤×éÖ¯ÃâÊܲ»Á¼Ó°Ïì¡£

   ÆäÖУ¬£¬ÍʺÚËØÔö²¹ºó£¬£¬×ãÇòÔË·¢¶¯µÄÍʺÚËØºÍÒìǰÏßÏÙËØÅ¨¶È¾ùÏÔÖøµÍÓÚ±ÈÕÕ×飬£¬¶ø»®´¬ÔË·¢¶¯µÄ»¹Ô­Ð͹Èë׸ÊëÄ(GSH)Ũ¶ÈÓë±ÈÕÕ×é¿¿½üµ«¸ßÓÚ×ãÇòÔË·¢¶¯¡£

   ¿´À´£¬£¬ÍʺÚËØÔö²¹ÄÜÏÔÖøµ÷ÀíÔË·¢¶¯µÄÑõ»¯Ó¦¼¤ºÍÑ×Ö¢±ê¼ÇÎï¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDYvMWUwNGEyYjE0YzIzNjJmODhlN2MxNmQwYzBjZDhiYTgucG5n

ÂÛÎÄÊ×Ò³½ØÍ¼


   ¸ßÇ¿¶ÈµÄÌåÓýÄ¥Á¶ºÍѵÁ·»áµ¼ÖÂÔË·¢¶¯ÌåÄÚ·ºÆðÑõ»¯Ó¦¼¤ºÍÑ×Ö¢±ê¼ÇÎï¡£µ±ÉíÌå¾ÙÐиßÇ¿¶ÈµÄÔ˶¯Ê±£¬£¬»áÔöÌíÑõµÄÉãÈ¡ºÍʹÓ㬣¬´Ó¶øÔöÌíÌåÄÚ×ÔÓÉ»ùµÄ±¬·¢¡£

   ¼ÈÈ»ÔÆÔÆ£¬£¬ÊÇ·ñͨ¹ý´ÓÔö²¹ÍʺÚËØ£¬£¬ÔÚÑõ»¯Ó¦¼¤ºÍÑ×Ö¢·´Ó³ÉÐδ¼Ó¾çʱ£¬£¬ïÔÌ­±¬·¢ÕâЩ±ê¼ÇÎïÄØ£¿£¿

   Ñо¿ÕßÕÐļÁË81ÃûÄÐÐÔ¼ÓÈëÕߣ¬£¬ÆäÖÐ47Ãû×ãÇòÔË·¢¶¯¡¢¡¢19Ãû»®´¬ÔË·¢¶¯ºÍ15Ãû²»¾ÙÐÐÌåÓýÄ¥Á¶µÄÇàÄêÄÐÐÔ×÷Ϊ±ÈÕÕ×顣ΪÁËÈ·±£Ñо¿µÄ׼ȷÐÔ£¬£¬ÕâЩ¼ÓÈëÕß¶¼Ã»Óоƾ«ºÍ/»òÑ̲ݳÉñ«¡¢¡¢ÌÇÄò²¡¡¢¡¢Ô­·¢ÐÔ¸ßѪѹ¡¢¡¢È±ÑªÐÔÐÄÔಡ¡¢¡¢ÖзçºÍÉö¹¦Ð§Ë¥½ßµÈÒÑÖªµÄ×ÔÓÉ»ù²¡Òò¡£ÔÚ¾ÙÐÐÍʺÚËØÔö²¹Ö®Ç°£¬£¬ËùÓÐÔË·¢¶¯¶¼¾­ÓÉÁËΪÆÚ30ÌìµÄ½ÇÖð×¼±¸ÆÚ£¬£¬²¢¾ÙÐÐÁËһϵÁеÄËÙÂÊ-ÄÍÁ¦ÑµÁ·¡£

   Éú»¯ÆÊÎö°üÀ¨¶ÔѪÇåÖеÄÍʺÚËØ¡¢¡¢ÒìǰÏßÏÙËØ¡¢¡¢¿¹Ñõ»¯-LDL¿¹Ìå¡¢¡¢IL-6ºÍCRPµÄŨ¶È¾ÙÐÐøÃâÒ߲ⶨ£¬£¬ÒÔ¼°Ê¹ÓÃBeutlerµÄÒªÁì¶Ôºìϸ°ûÖеĻ¹Ô­Ð͹Èë׸ÊëÄ£¨GSH£©µÄŨ¶È¾ÙÐвⶨ¡£

   Ñо¿Ð§¹ûÒýÈËעĿ£¬£¬ÓëÑõ»¯Ó¦¼¤ºÍÑ×Ö¢±ê¼ÇÎïÏÔÖøÏà¹ØµÄÉú»¯²ÎÊýÖ÷ÒªÊÇÍʺÚËØ¡¢¡¢ÒìǰÏßÏÙËØ¡¢¡¢»¹Ô­Ð͹Èë׸ÊëĵÈ¡£ÌØÊâÊÇÔÚ×ãÇòÔË·¢¶¯ºÍ»®´¬ÔË·¢¶¯ÖУ¬£¬ÕâЩ±ê¼ÇÎïµÄŨ¶ÈÓë±ÈÕÕ×é±£´æÏÔÖø²î±ð£¬£¬Åú×¢ÍʺÚËØÔö²¹¶ÔÕâЩ±ê¼ÇÎïÓÐÏÔÖøµÄµ÷Àí×÷Óá£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDYvMzlhMDExNGIxODRjZmM4ZDBmMWE0Mzk2ODFhMTVjMjMucG5n

½ÏÁ¿²î±ðʱ¼äµã±ÈÕÕ×飬£¬×ãÇòÔË·¢¶¯ºÍ»®´¬ÔË·¢¶¯Ö®¼äµÄѪÇåÍʺڼ¤ËØÅ¨¶È


   ÑªÇåÖеÄÍʺÚËØÅ¨¶ÈÔÚ²î±ðʱ¼äµãÔÚ±ÈÕÕ×é¡¢¡¢×ãÇòÔË·¢¶¯ºÍ»®´¬ÔË·¢¶¯Ö®¼ä±£´æÏÔÖø²î±ð¡£×ãÇòÔË·¢¶¯µÄÍʺÚËØÅ¨¶ÈÔÚ½ÇÖðºóÏÔÖøÏ½µ£¬£¬¶ø»®´¬ÔË·¢¶¯µÄŨ¶ÈÔÚ½ÇÖðºóÂÔÓÐÉÏÉý¡£±ðµÄ£¬£¬±ÈÕÕ×éµÄÍʺÚËØÅ¨¶ÈÔÚÕû¸öÑо¿Ê±´úÏà¶ÔÎȹÌ¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDYvM2I1NTNiMjAwMDU5MzM4YzU0ZWE1MGI1YmUxZDRjZjkucG5n

½ÏÁ¿²î±ðʱ¼äµã±ÈÕÕ×飬£¬×ãÇòÔË·¢¶¯ºÍ»®´¬ÕßÖ®¼äµÄºìϸ°û½µµÍ¹Èë׸ÊëÄ£¨GSH£©Å¨¶È


   ±ÈÕÕ×é¡¢¡¢×ãÇòÔË·¢¶¯ºÍ»®´¬ÔË·¢¶¯µÄGSHŨ¶È»®·ÖΪ2.64 ± 0.25 mmol/L¡¢¡¢2.43 ± 0.28 mmol/LºÍ2.73 ± 0.27 mmol/L¡£×ãÇòÔË·¢¶¯µÄGSHŨ¶ÈÏà¶Ô½ÏµÍ£¬£¬¶ø»®´¬ÔË·¢¶¯µÄGSHŨ¶ÈÓë±ÈÕÕ×éÏà½ü¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDYvYjZkNzQxYmI1ZDE1YmQxOTVjYTNmMGZlYTdlZjhmYzQucG5n

½ÏÁ¿²î±ðʱ¼äµã±ÈÕÕ×飬£¬×ãÇòÔË·¢¶¯ºÍ»®´¬ÔË·¢¶¯Ö®¼äµÄѪÇåÒìǰÏßËØÅ¨¶È


   ÔÚ²î±ðʱ¼äµã£¬£¬×ãÇòÔË·¢¶¯¡¢¡¢»®´¬ÔË·¢¶¯ºÍ±ÈÕÕ×éÖ®¼äµÄѪÇåÒìǰÏßÏÙËØÅ¨¶È±£´æÏÔÖø²î±ð¡£×ãÇòÔË·¢¶¯µÄŨ¶ÈÔÚ½ÇÖðºóϽµÖÁ625 ± 244 pg/mL£¬£¬¶ø»®´¬ÔË·¢¶¯µÄŨ¶ÈÎȹÌÔÚ676 ± 299 pg/mL¡£²»¹ý£¬£¬ÕâÁ½×éÔË·¢¶¯µÄÒìǰÏßÏÙËØÅ¨¶È¾ù¸ßÓÚ±ÈÕÕ×é¡£


   ¹ØÓÚ»úÖÆ£¬£¬ÍʺÚËØ¼°Æä´úл²úÆ·¿ÉÒÔÖ±½Óɨ³ý»îÐÔÑõºÍµª£¨RONS£©£¬£¬ÕâÒ»Àú³Ì±»³ÆÎª×ÔÓÉ»ùɨ³ý¼¶Áª£¬£¬Ê¹ÍʺÚËØÓëÆäËû¿¹Ñõ»¯¼ÁÓÐËùÇø±ð¡£ÍʺÚËØµÄ¼ä½Ó¿¹Ñõ»¯»îÐÔÓëÆäͨ¹ýµ÷Àíø»îÐÔ»ò»ùÒò±í´ïÀ´´Ì¼¤¿¹Ñõ»¯Ã¸£¨È糬Ñõ»¯ÎïÆç»¯Ã¸¡¢¡¢¹Èë׸ÊëĹýÑõ»¯ÎïøºÍ¹ýÑõ»¯Çâø£©µÄ»îÐÔÓйØ¡£±ðµÄ£¬£¬ÍʺÚËØ»¹¼ÓÈëά³Ö¸ßŨ¶ÈµÄ»¹Ô­Ð͹Èë׸ÊëÄ£¨GSH£©£¬£¬ÓÉÓÚÕâÖÖßÅßá°·À໯ºÏÎï¿ÉÒÔÓÕµ¼GSHºÏ³ÉµÄËÙÂÊÏÞÖÆÃ¸γ-¹È°±õ£ë×°±ËáºÏøµÄ»îÐÔ¡£


   Ò²¾ÍÊÇ˵£¬£¬ÍʺÚËØ¿ÉÄÜ×ÊÖúÎÒÃÇïÔÌ­Á˲¿·Ö´ÙÑס¢¡¢´ÙÖ¬ÖʹýÑõ»¯µÄ»îÐÔÑõºÍµª¡£


   ±¾Ñо¿Õ¹ÏÖÁËÍʺÚËØÔÚµ÷ÀíÔ˶¯ºóµÄÑõ»¯Ó¦¼¤ºÍÑ×Ö¢·´Ó³ÖеÄÖ÷Òª×÷Óá£Ñо¿ÕßÒÔΪ£¬£¬ÍʺÚËØ¼°Æä´úл²úÆ·ÓÐÍû³ÉΪÔË·¢¶¯ºÍÆäËûÈËȺÖÐïÔÌ­Ñõ»¯ËðÉ˺ÍÑ×Ö¢µÄÓÐÓÃÊֶΡ£µ«ÒªÊµÏÖÕâһĿµÄ£¬£¬ÎÒÃÇ»¹ÐèÒª¸üÉîÈëµØÑо¿Æä×÷ÓûúÖÆ£¬£¬²¢Í¨¹ý¸ü¶àµÄÁÙ´²ÊÔÑéÀ´ÑéÖ¤ÆäЧ¹û¡£


   ²Î¿¼ÎÄÏ×£º£º£º

    [1] J. Czuczejko, ?. Sielski, B. Wo?niak, A. Wo?niak, and K. Szewczyk-Golec, “Melatonin supplementation improves oxidative and inflammatory state in the blood of professional athletes during the preparatory period for competitions,” Free Radic. Res., vol. 53, no. 2, pp. 198–209, 2019, doi: 10.1080/10715762.2018.1563688.

]]>
/?feed=rss2&p=40220 0
άÉúËØB12ÓëÔË·¢¶¯µÄºìϸ°û£º£º£ºÒ»ÏîÐÂÑо¿Õ¹ÏÖÁËÁ½ÕßÖ®¼äµÄ¹ØÏµ /?p=40184 /?p=40184#comments Tue, 27 May 2025 03:14:25 +0000 http://www.jialanhai.com/?p=40184

ÉÅʳGABAµÄÉñÃØÊµÁ¦£º£º£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³×

2025-09-30 14:06

   Î¬ÉúËØB12ÔÚÈËÌåÖеÄÁ½ÖÖÉúÎï»îÐÔÐÎʽÓëºìϸ°ûµÄÐγÉÓйØ£¬£¬Õâ¶ÔÔË·¢¶¯µÄÌåÏÖÖÁ¹ØÖ÷Òª¡£Ö»¹ÜάÉúËØB12ÔÚÔ˶¯ÁìÓòÖÐÊܵ½ÆÕ±é¹Ø×¢£¬£¬µ«¹ØÓÚÆäÓëÔ˶¯ÌåÏÖÖ®¼ä¼òÖ±ÇйØÏµµÄÑо¿ÈÔÈ»ÓÐÏÞ¡£ÈÕǰ£¬£¬²¨À¼µÄ¿ÆÑÐÖ°Ô±ÔÚNutrientsÔÓÖ¾½ÒÏþÁËÐÂÑо¿°¸Àý£¬£¬Åú×¢½¨ÒéÔË·¢¶¯Ó¦¼á³ÖάÉúËØB12Ũ¶ÈÔÚ400-700 pg/mL¹æÄ£ÄÚÒÔÓÅ»¯ºìϸ°û²ÎÊý£¬£¬ÇÒŨ¶ÈµÍÓÚ400 pg/mLµÄÔË·¢¶¯¿ÉÄÜÐèÒªÔö²¹Î¬ÉúËØB12[1]¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDUvZjI3ODE4MGE4OWUxMzVmZmE2NmNjMzM2MjY0MGQzNTYucG5n


1.άÉúËØB12£º£º£º²»µ«½öÊÇÒ»¸öάÉúËØ


   Î¬ÉúËØB12£¬£¬ÊÇÒ»ÖÖË®ÈÜÐÔάÉúËØ£¬£¬¹ØÓÚÈËÌåµÄ¿µ½¡ºÍ¹¦Ð§ÖÁ¹ØÖ÷Òª¡£ÔÚÉúÎﻯѧ²ãÃæ£¬£¬Ëü×÷ΪijЩҪº¦Ã¸µÄ¸¨Ã¸£¬£¬¼ÓÈëÁ˶àÖÖÉúÎﻯѧ·´Ó³£¬£¬°üÀ¨DNAºÏ³É¡¢¡¢Ö¬·¾ºÍ°±»ùËáµÄ´úлÒÔ¼°Éñ¾­ÇÊÖ¬µÄÉú²ú¡£ÌØÊâÊÇÔÚºìϸ°ûµÄÌìÉúÖУ¬£¬Î¬ÉúËØB12Æðµ½Á˲»¿É»òȱµÄ×÷Ó᣺£º£ºìϸ°ûÈÏÕæ½«ÑõÆø´Ó·Î²¿ÔËË͵½ÉíÌåµÄ¸÷¸ö²¿Î»£¬£¬Õâ¹ØÓÚËùÓÐÈË£¬£¬ÓÈÆäÊÇÔË·¢¶¯À´Ëµ£¬£¬¶¼ÊÇÖÁ¹ØÖ÷ÒªµÄ¡£Ò»¸ö¿µ½¡µÄºìϸ°û¼ÆÊý¿ÉÒÔÈ·±£ÉíÌå×éÖ¯»ñµÃ¸»×ãµÄÑõÆø£¬£¬´Ó¶øÎ¬³ÖÆä¹¦Ð§²¢Ö§³ÖÉíÌåµÄ»î¶¯¡£

2.ÔË·¢¶¯ÎªºÎÌåÌùάÉúËØB12


   ¹ØÓÚÔË·¢¶¯À´Ëµ£¬£¬Î¬ÉúËØB12µÄÖ÷ÒªÐÔ¸üÊDz»ÑÔ¶øÓ÷¡£Ê×ÏÈ£¬£¬Ëü¹ØÓÚÄÜÁ¿´úлÖÁ¹ØÖ÷Òª¡£ÔË·¢¶¯ÐèÒª´ó×ÚµÄÄÜÁ¿À´Ö§³ÖËûÃǵÄѵÁ·ºÍ½ÇÖ𣬣¬¶øÎ¬ÉúËØB12ÔÚ×ÊÖúÉíÌå´ÓʳÎïÖÐÌáÈ¡ÄÜÁ¿µÄÀú³ÌÖÐÆðµ½ÁËÒªº¦×÷ÓᣱðµÄ£¬£¬Î¬ÉúËØB12¹ØÓÚÉñ¾­ÏµÍ³µÄ¿µ½¡Ò²ºÜÊÇÖ÷Òª¡£Ò»¸ö¿µ½¡µÄÉñ¾­ÏµÍ³¿ÉÒÔÈ·±£Éñ¾­ÐźŵĿìËÙºÍ׼ȷ´«Ê䣬£¬Õâ¹ØÓÚÔË·¢¶¯µÄ·´Ó³ËÙÂʺÍЭµ÷ÐÔÖÁ¹ØÖ÷Òª¡£×îºó£¬£¬Î¬ÉúËØB12»¹ÓëÃâÒßϵͳµÄ¿µ½¡ÓйØ¡£¸ßÇ¿¶ÈµÄѵÁ·ºÍ½ÇÖð¿ÉÄÜ»á¶ÔÃâÒßϵͳÔì³ÉѹÁ¦£¬£¬¶øÊÊÁ¿µÄάÉúËØB12ÉãÈë¿ÉÒÔ×ÊÖúÔË·¢¶¯Î¬³ÖÃâÒßϵͳµÄ¿µ½¡£¬£¬´Ó¶øïÔÌ­Òò¼²²¡µ¼ÖµÄѵÁ·ºÍ½ÇÖðÖÐÖ¹¡£

3.×îÐÂÑо¿Êý¾Ý


   ¿ËÈÕ£¬£¬NutrientsÔÓÖ¾ÉϽÒÏþÁËһƪÓɲ¨À¼²¨×ÈÄÏ´óѧҽѧ¿ÆÑ§Ñ§ÔºµÄÑо¿ÍŶÓ׫дµÄÎÄÕ£¬£¬ÉîÈë̽ÌÖÁËάÉúËØB12ÓëÔË·¢¶¯ºìϸ°ûÖ®¼äµÄ¹ØÏµ¡£ÔÚÕâÏîÑо¿ÖУ¬£¬¶Ô243ÃûÌï¾¶ÔË·¢¶¯µÄѪҺÑù±¾¾ÙÐÐÁËÆÊÎö£¬£¬ÒÔ̽ÌÖάÉúËØB12Ũ¶ÈÓëÔ˶¯ÌåÏÖÖ®¼äµÄ¹ØÏµ¡£

   ËùÓÐÊÜÊÔÕߵį½¾ùάÉúËØB12Ũ¶ÈΪ739 ¡À 13 pg/mL¡£ÊµÁ¦ÐÍÔË·¢¶¯µÄŨ¶ÈΪ703 ¡À 15 pg/mL£¬£¬¶øÄÍÁ¦ÐÍÔË·¢¶¯µÄŨ¶ÈΪ881 ¡À 32 pg/mL£¬£¬ÏÔʾÄÍÁ¦ÐÍÔË·¢¶¯µÄάÉúËØB12Ũ¶ÈÏÔÖø¸ßÓÚʵÁ¦ÐÍÔË·¢¶¯¡£±ðµÄ£¬£¬ÊµÁ¦ÔË·¢¶¯µÄάÉúËØB12Ũ¶ÈµÍÓÚ300, 350ºÍ400 pg/mLµÄÑù±¾ÊýÄ¿ÏÔ×ŶàÓÚÄÍÁ¦ÔË·¢¶¯£¬£¬¶øÁè¼Ý700 pg/mLµÄŨ¶ÈÔÚÄÍÁ¦ÔË·¢¶¯ÖиüΪ³£¼û¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDUvMTkwNmUwN2UxYzQ0YmUyOGNkYWQxNjQ4YTQ4ZTY2MzcucG5n

ͼ1£º£º£ºÊµÁ¦ÐͺÍÄÍÁ¦ÐÍÔË·¢¶¯ÖУ¬£¬Î¬ÉúËØB12Ũ¶ÈµÍÓÚ300¡¢¡¢350ºÍ400 pg/mLÒÔ¼°¸ßÓÚ700 pg/mLµÄÑù±¾ÊýÄ¿ºÍ°Ù·Ö±È¡£


   ¸üΪÖ÷ÒªµÄÊÇ£¬£¬Ñо¿»¹·¢Ã÷ÁËѪºìÂѰ×Ũ¶ÈÓëάÉúËØB12Ũ¶ÈÖ®¼äµÄ¹ØÏµ¡£ÑªºìÂѰ×ÊǺìϸ°ûÖеÄÒ»¸öÒªº¦ÂѰ×ÖÊ£¬£¬ÈÏÕæÐ¯´øÑõÆø¡£Ñо¿ÏÔʾ£¬£¬Î¬ÉúËØB12Ũ¶È½Ï¸ßµÄÔË·¢¶¯£¬£¬ÆäѪºìÂѰ×Ũ¶ÈÒ²ÏìÓ¦½Ï¸ß£¬£¬ÕâÒâζ×ÅËûÃǵÄÑõÆøÔËËÍÄÜÁ¦¿ÉÄܸüÇ¿¡£

   ¹ØÓÚºìϸ°û²ÎÊý£¬£¬Ñо¿·¢Ã÷άÉúËØB12ÓëѪºìÂѰ×Ũ¶È¡¢¡¢ÑªÏ¸°û±ÈÈÝ¡¢¡¢Æ½¾ùϸ°ûÌå»ý£¨MCV£©Çå¾²¾ùϸ°ûѪºìÂѰף¨MCH£©Ö®¼ä±£´æÈõµ«Í³¼ÆÑ§ÉÏÏÔÖøµÄÕýÏà¹Ø¹ØÏµ¡£ÕâÒâζ×ÅάÉúËØB12Ũ¶ÈµÄÔöÌí¿ÉÄÜÓëÕâЩºìϸ°û²ÎÊýµÄ¸ÄÉÆÓйØ£¬£¬´Ó¶ø¿ÉÄÜÓ°ÏìÔË·¢¶¯µÄÔ˶¯ÌåÏÖ¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDUvNWQ4ZjkxZGE5OWZmYzc5MWFhNGNlZTk5MzU5ZDMzYzYucG5n

ͼ2£º£º£º×ÜѪÇåάÉúËØB12Ũ¶ÈÓëѪҺѧָ±êÖ®¼äµÄÏà¹ØÐÔ£º£º£ºÑªºìÂѰ×Ũ¶È¡¢¡¢ÑªÏ¸°û±ÈÈÝ¡¢¡¢Æ½¾ùϸ°ûÌå»ý£¨MCV£©Çå¾²¾ùϸ°ûѪºìÂѰף¨MCH£©¡£

   ÕâЩÊý¾ÝÕ¹ÏÖÁËάÉúËØB12Ũ¶ÈÓëÔË·¢¶¯µÄÔ˶¯ÀàÐÍÖ®¼äµÄ¹ØÏµ£¬£¬ÒÔ¼°Î¬ÉúËØB12Ũ¶È¶ÔÔ˶¯ÌåÏÖµÄDZÔÚÔöÒæÐ§¹û¡£ÓÈÆäÊÇÔÚÄÍÁ¦Ô˶¯ÖУ¬£¬½Ï¸ßµÄάÉúËØB12Ũ¶È¿ÉÄÜÓë¸üºÃµÄÔ˶¯ÌåÏÖÓйØ¡£

4.½áÂÛ


   ¸ÃÑо¿Ì½ÌÖÁËÔË·¢¶¯ÌåÄÚάÉúËØB12Ũ¶ÈÓëºìϸ°û²ÎÊýÖ®¼äµÄ¹ØÏµ¡£Ð§¹ûÏÔʾ£¬£¬Î¬ÉúËØB12Ũ¶ÈÓëѪºìÂѰ×Ũ¶ÈÖ®¼ä±£´æÕýÏà¹Ø£¬£¬ÇÒµ±Î¬ÉúËØB12Ũ¶ÈΪ488 pg/mLʱ£¬£¬¿ÉÒÔµÖ´ïѪºìÂѰ׵ı¥ºÍˮƽµÄ99%¡£±ðµÄ£¬£¬Î¬ÉúËØB12×¢Éä¿ÉÒÔÏÔÖøÌá¸ßѪºìÂѰ×Ũ¶È¡£Òò´Ë£¬£¬½¨ÒéÔË·¢¶¯Î¬³Ö400-700 pg/mLµÄάÉúËØB12Ũ¶È£¬£¬ÒÔÓÅ»¯ºìϸ°û²ÎÊý¡£Î´À´µÄÑо¿Ó¦½øÒ»²½Ì½Ë÷άÉúËØB12ÓëÆäËûÐÄÀíÖ¸±êÖ®¼äµÄ¹ØÏµ£¬£¬ÒÔ¸üÖÜÈ«µØÏàʶÆäÔÚÔ˶¯ÌåÏÖÖеÄ×÷Óá£

²Î¿¼ÎÄÏ×£º£º£º

[1] J. Krzywa¨½ski et al., ¡°Vitamin B12 status and optimal range for hemoglobin formation in elite athletes,¡± Nutrients, vol. 12, no. 4, 2020, doi: 10.3390/nu12041038.

·ÖÏíµ½£º£º£º

ÔĶÁ¸ü¶àÎÄÕÂ
READ MORE

]]>
/?feed=rss2&p=40304 0
Í»ÆÆCoQ10ÎüÊÕÆ¿¾±£º£º£ºÊÍ·ÅÎÞÖ¬ÖÊÄÉÃ×ÖÆ¼ÁµÄDZÄÜ /?p=40159 /?p=40159#comments Mon, 28 Apr 2025 01:46:09 +0000 http://www.jialanhai.com/?p=40159

ÉÅʳGABAµÄÉñÃØÊµÁ¦£º£º£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³×

2025-09-30 14:06

   ¸¨Ã¸Q10ÎüÊÕÂʽϵ͵ÄÖ÷ÒªÔ­ÒòÖ®Ò»ÊÇÆäÖ¬ÈÜÐÔÌØÕ÷ÓëÏû»¯µÀÇéÐεIJ»Æ¥Åä¡£Ö¬ÈÜÐÔ·Ö×ÓÔÚË®ÐÔµÄ賦µÀÖÐÄÑÒÔÏûÈÚ£¬£¬´Ó¶øÏÞÖÆÁËÆäÓÐÓÃÎüÊÕ¡£±ðµÄ£¬£¬Î¸ËáºÍÒÈÒºµÄ±£´æ¿ÉÄܻᵼÖ¸¨Ã¸Q10µÄ½µ½â£¬£¬Ó°ÏìÆäÉúÎï»îÐÔºÍÎüÊÕЧ¹û¡£Í¬Ê±£¬£¬¸¨Ã¸Q10¿ÉÄÜÓëÆäËûÖ¬ÈÜÐÔÎïÖʾºÕùÎü¸½ÔÚ³¦±ÚÉÏ£¬£¬´Ó¶øÏÞÖÆÁËÆä½øÒ»²½µÄÎüÊÕ¡£±ðµÄ£¬£¬³¦ð¤Ä¤µÄÆÁÕϹ¦Ð§Ò²¿ÉÄÜÓ°Ï츨øQ10µÄ´©Í¸¡£

   ÎªÁËսʤÕâЩÏÞÖÆÒòËØ£¬£¬¶«ÄÏ´óѧÑо¿Ö°Ô±ÔÚ¡¶BioMed research international¡··¢ÎÄ¡¶Novel Lipid-Free Nanoformulation for Improving Oral Bioavailability of Coenzyme Q10¡·¶ÔÌá¸ß¸¨Ã¸Q10µÄÉúÎïʹÓöȺÍÎüÊÕЧÂÊÓÐÁ˸ü¶àÖ±¹ÛµÄÏàʶ[1]¡£

1.¸¨Ã¸Q10

   ¸¨Ã¸Q10£¨CoQ10£©ÊÇÏßÁ£ÌåºôÎüÁ´µÄÖ÷Òª×é³É²¿·Ö£¬£¬±£´æÓÚËùÓлîϸ°ûµÄÏßÁ£ÌåÄÚĤÖС£ËüÊÇÓÐÓõĿ¹Ñõ»¯¼Á£¬£¬¿ÉÒÔ·´¿¹×ÔÓÉ»ùºÍÖ¬ÖʹýÑõ»¯¡£Ðí¶àÑо¿±¨¸æÏÔʾ£¬£¬ÔÚÐÄѪ¹Ü¼²²¡¡¢¡¢Éñ¾­ÍËÐÐÐÔ¼²²¡¡¢¡¢ÌÇÄò²¡¡¢¡¢ËûÍ¡ÀàÒ©ÎïÏà¹Ø¼¡ÈâÌÛÍ´ºÍ°©Ö¢»¼ÕßÖб£´æ¸¨Ã¸Q10ȱ·¦¡£Ôö²¹¸¨Ã¸Q10Òѱ»Ö¤Êµ¶ÔÖÎÁÆÕâЩ¼²²¡ÓÐÒæ£¬£¬²¢ÇÒÐí¶àÁÙ´²ÊÔÑéÕýÔÚÊÓ²ìÆä×÷ΪҩÎï»òÉÅʳÔö²¹¼ÁµÄÓ¦Óá£

   ÓÐѧÕßÔÚSelf-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessmentÑо¿ÖÐ֤ʵ£¬£¬¸¨Ã¸Q10Ë®ÈÜÐÔ¼«²î¡¢¡¢µÍÉúÎïʹÓöȺÍת´ïÐÔ[2]¡£Òò´Ë£¬£¬Õë¶Ô¸¨Ã¸Q10µÄ¿Ú·þÖÎÁÆ·½°¸ÊÇ»ùÓÚÆä×Ô¼ºµÄÖ¬ÈÜÐÔ£¬£¬ÍƼöÓ븻º¬Ö¬ÖʵÄʳÎïͬʱ·þÓá£

2.Ìá¸ß¸¨Ã¸Q10µÄÉúÎïʹÓöÈ

   Í¨Ë׸¨Ã¸Q10µÄÉúÎïʹÓöÈÏà¶Ô½ÏµÍ£¬£¬×ÝÈ»ÔÚÅäºÏ¸»º¬Ö¬ÖʵÄʳÎïͬʱ·þÓ㬣¬ÆäÎüÊÕÂÊÒ²Ö»ÓÐÔ¼3%[3]¡£ÕâÊÇÓÉÓÚ¸¨Ã¸Q10ÊÇÖ¬ÈÜÐԵ쬣¬²¢ÇÒÔÚÌåÄÚµÄÎüÊÕºÍʹÓÃÊܵ½¶àÖÖÒòËØµÄÓ°Ï죬£¬°üÀ¨Æä×Ô¼ºµÄ»¯Ñ§ÐÔ×Ó¡¢¡¢Î¸³¦µÀµÄÐÄÀíÇéÐΡ¢¡¢ÒûʳÒòËØµÈ¡£ÏÖÔÚ£¬£¬³¯×Å¿ª·¢Ò»ÖÖº¬ÓÐÍâò»îÐÔ¼ÁµÄ¸ßÎüÊÕ¸¨Ã¸Q10ÄÉÃ×ÖÆ¼ÁµÄÆ«ÏòÂõ½øÒѳÉΪδÀ´µÄ¿ªÕ¹Ç÷ÊÆ¡£

   ¶«ÄÏ´óѧµÄÑо¿ÍŶÓÔÚ¡¶BioMed Research International¡·ÔÓÖ¾ÉϽÒÏþµÄÂÛÎÄ¡¶Novel Lipid-Free Nanoformulation for Improving Oral Bioavailability of Coenzyme Q10¡·ÖÐÕ¹ÏÖ£¬£¬Í¨¹ýÎȹÌÍâò»îÐÔ¼ÁµÄÎÞÖ¬ÖÊÄÉÃ×CoQ10ϵͳ£¬£¬¿ÉÄܳÉΪÌá¸ß¿Ú·þCoQ10ÉúÎïʹÓöȵÄÓÐÓÃÔØÌå¡£

Ê×Ò³| w66À´Àû¹ú¼ÊÆì½¢Ìü¹ÙÍø

   Ñо¿½ÓÄɸßÄÜÒªÁìºÍ¸ßѹ¾ùÖÊ»úÖÆ±¸ÁËÄÉÃ×CoQ10ÖÆ¼Á¡£Ã¿ÖÖÄÉÃ×CoQ10ÖÆ¼Á¶¼¾­ÓÉÍâò»îÐÔ¼ÁÎȹÌ£¬£¬ÕâЩÍâò»îÐÔ¼Á¾ßÓвî±ðµÄÇ×Ë®»ùÍÅ£¬£¬Òò´Ëµ¼ÖÂÁ˲î±ðµÄƽ¾ù¿ÅÁ£¾Þϸ£¬£¬ÏêϸÊý¾ÝÏê¼ûÏ·½Áбí¸ñ¡£ÕâЩÏà¶Ô½ÏСµÄƽ¾ù¿ÅÁ£¾ÞϸÔÚÌáÉýÉúÎïʹÓöȷ½Ãæ¾ßÓÐÎüÒýÁ¦£¬£¬ÓÉÓÚÆ½¾ù¿ÅÁ£¾ÞϸÊÇÓ°ÏìÄÉÃ×ÖÆ¼ÁÉúÎïʹÓöȵÄÖ÷ÒªÒòËØÖ®Ò»¡£ÔÚ½ºÌåµÝËÍϵͳÖУ¬£¬µ±¿ÅÁ£³ß´çËõСÖÁÄÉÃ×³ß´ç¹æÄ£Ê±£¬£¬·â×°µÄÇ×Ö¬»¯ºÏÎïµÄ¿Ú·þÉúÎïʹÓöÈÒ²»áÔöÌí¡£

Ê×Ò³| w66À´Àû¹ú¼ÊÆì½¢Ìü¹ÙÍø

²î±ðÍâò»îÐÔ¼ÁÐÞÊεÄÄÉÃ×CoQ10µÄÎïÀí»¯Ñ§ÐÔ×ÓÒÔ¼°ÄÉÃ×CoQ10ÔÚÃÜ·â×ØÉ«Æ¿ÖÐÖü´æ180Ììʱ´úÔÚ25¡æÌõ¼þϵÄÎȹÌÐÔ¡£


      ÄÉÃ×CoQ10µÄÎïÀí״̬Ñо¿Õ¹ÏÖÁËÆäÓëͨË×CoQ10µÄ²î±ð£¬£¬ºóÕßÔÚ¼ÓÈÈʱ»á³ÊÏÖÌØÕ÷ÐÔµÄÎüÈȷ壬£¬¶øÄÉÃ×CoQ10ÔòûÓÐÕâÖÖÌåÏÖ¡£Æä³¬Àä̬µÄ±£´æ¿ÉÄÜÊÇÄÉÃ׳ߴçЧӦËùÖ£¬£¬Õâһ״̬ÔÚÎïÀí»¯Ñ§ÉϾßÓÐÎȹÌÐÔµÄÓÅÊÆ£¬£¬¿É×èÖ¹½á¾§£¬£¬Ìṩ½Ï³¤Ê±¼äµÄ¼á³ÖÎȹÌÐÔ¡£È»¶ø£¬£¬³¬Àä̬µÄ²»ÎȹÌÐÔÒ²ÐèÒª½øÒ»²½Ñо¿ÒÔ¸üÖÜÈ«µØÏàʶÆäÔÚÒ©Îï²úÆ·ÖеÄÊÊÓÃÐÔºÍÎȹÌÐÔ¡£


Ê×Ò³| w66À´Àû¹ú¼ÊÆì½¢Ìü¹ÙÍø

¸¨Ã¸Q10¡¢¡¢Íâò»îÐÔ¼ÁºÍÄÉÃ׸¨Ã¸Q10µÄDSC£¨²îʾɨÃèÁ¿ÈÈ·¨£©ÇúÏß


   Ö¬ÈÜÐÔ¸¨ÁÏÔÚÅäºÏ¿Ú·þµÄÖ¬ÈÜÐÔÒ©ÎïÎüÊÕ·½Ãæ¾ßÓÐÏÔÖøÓ°Ïì¡£Íâò»îÐÔ¼Á¿ÉÒԸıäϸ°ûĤÍêÕûÐÔºÍϸÃÜÅþÁ¬£¬£¬Í¬Ê±ÒÖÖÆP-ÌÇÂѰ׵ÈÍâÅÅתÔËÌå¡£ÕâЩÍâò»îÐÔ¼ÁÓÐÍû¼õÇá¿Ú·þÒ©ÎïÉúÎïʹÓöȵÄÏÞÖÆ£¬£¬ÓÈÆäÊÇͨ¹ýÒÖÖÆP-ÌÇÂѰ׵Ä×÷Óá£ÔÚ¿Ú·þºó£¬£¬Ê¹ÓÃÍâò»îÐÔ¼Á¾ÙÐÐÐÞÊοÉÌá¸ß¸¨Ã¸Q10µÄAUC£¨Ò©ÎïÇúÏßϵÄÃæ»ý£©£¬£¬ÆäЧ¹ûÅÅÐòΪ£º£º£º

   PHCO¡ÖPSAE > SP ¡Ö TPGS > SL¡£

Ê×Ò³| w66À´Àû¹ú¼ÊÆì½¢Ìü¹ÙÍø

ÄÉÃ׸¨Ã¸Q10ºÍÍâò»îÐÔ¼Á¡¢¡¢¸¨Ã¸Q10µÄѪҩŨ¶È±ÈÕÕ


   Ñо¿Öн«¸¨Ã¸Q10ÖÆ±¸ÎªÎÞÖ¬ÖÊÄÉÃ׸¨Ã¸Q10ϵͳ£¬£¬ÒÔÌá¸ßÆäÏûÈڶȺͿڷþÉúÎïʹÓöÈ¡£½ÓÄɲî±ðÍâò»îÐÔ¼Á¶ÔÄÉÃ׸¨Ã¸Q10¾ÙÐÐÐÞÊΣ¬£¬Ð§¹ûÏÔʾÎÞÖ¬ÖÊÄÉÃ׸¨Ã¸Q10ÔÚ¿Ú·þºóÏÔÖøÌá¸ßÁ˸¨Ã¸Q10µÄÉúÎïʹÓöÈ¡£


   Ñо¿Åú×¢£¬£¬Íâò»îÐÔ¼ÁÔÚ¸ÄÉÆ¸¨Ã¸Q10ÉúÎïʹÓöȷ½ÃæÊ©Õ¹ÁËÖ÷Òª×÷Ó㬣¬ÐÞÊκóµÄÎÞÖ¬ÖÊÄÉÃ׸¨Ã¸Q10µÄÉúÎïʹÓöÈÉõÖÁÁè¼ÝÁË»ùÓÚÖ¬ÖʵÄÄÉÃ×ÈéÒº¡£Òò´Ë£¬£¬ÎÞÖ¬ÖÊÄÉÃ׸¨Ã¸Q10ÖÆ¼ÁÔÚÌá¸ß¸¨Ã¸Q10¿Ú·þÉúÎïʹÓöȷ½Ãæ¾ßÓÐDZÔÚÓ¦ÓüÛÖµ£¬£¬Íâò»îÐÔ¼ÁÔÚÆäÖÐÊÎÑÝÒªº¦½ÇÉ«¡£


Reference£º£º£º

[1] H. Zhou et al., ¡°Novel Lipid-Free Nanoformulation for Improving Oral Bioavailability of Coenzyme Q10,¡± Biomed Res. Int., vol. 2014, 2014.

[2] Tr. Kommuru, B. Gurley, M. A. Khan, and I. K. Reddy, ¡°Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment,¡± Int. J. Pharm., vol. 212, no. 2, pp. 233¨C246, 2001.

[3] K. Nukui, T. Yamagishi, H. Miyawaki, A. Kettawan, T. Okamoto, and K. Sato, ¡°Comparison of uptake between PureSorb-QTM 40 and regular hydrophobic coenzyme Q10 in rats and humans after single oral intake,¡± J. Nutr. Sci. Vitaminol. (Tokyo)., vol. 53, no. 2, pp. 187¨C190, 2007, doi: 10.3177/jnsv.53.187.

·ÖÏíµ½£º£º£º

ÔĶÁ¸ü¶àÎÄÕÂ
READ MORE

]]>
/?feed=rss2&p=40304 0
¿ÚÇ»ð¤Ä¤µÝËÍ£º£º£º×¿Ô½µÄÓªÑøËØÎüÊÕ;¾¶ /?p=40087 /?p=40087#comments Tue, 25 Mar 2025 06:53:24 +0000 http://www.jialanhai.com/?p=40087

ÉÅʳGABAµÄÉñÃØÊµÁ¦£º£º£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³×

2025-09-30 14:06

   ÓªÑøËصÝËÍͨµÀÊÇÖ¸½«ÓªÑøËØ£¨ÈçάÉúËØ¡¢¡¢¿óÎïÖÊ¡¢¡¢ÂѰ×Öʵȣ©´ÓÍâ½çÎüÊÕ²¢ÔËË͵½Ï¸°ûÄÚ£¬£¬ÒÔÖª×ãÉíÌåµÄÓªÑøÐèÇó¡£ÓªÑøËصÝËÍͨµÀ¿ÉÒÔ·ÖΪ¿Ú·þ¡¢¡¢¿ÚǻճĤ¡¢¡¢×¢ÉäµÈ£¬£¬Ã¿ÖÖ·½Ê½¶¼ÓÐÆäÌØ¶¨µÄÓÅÊÆºÍÊÊÓó¡¾°¡£


   ÔÚ¿Ú·þ·½Ê½ÖУ¬£¬ÓªÑøËØ¿ÉÒÔͨ¹ý賦µÀ±»ÎüÊÕ£¬£¬È»ºó½øÈëѪҺѭ»·£¬£¬±»ÔËË͵½ÉíÌå¸÷¸ö²¿Î»¡£¶ø¿ÚÇ»ð¤Ä¤ÎüÊÕͨµÀÊÇÒ»ÖÖͨ¹ý¿ÚÇ»ð¤Ä¤Ñ¸ËÙÎüÊÕÓªÑøËØµÄ·½Ê½£¬£¬×èÖ¹ÁËθËáµÈÒòËØµÄÓ°Ï죬£¬´Ó¶øÊµÏÖ¸ü¿ìµÄЧ¹û¡£


   ×¢ÉäÊÇÁíÒ»ÖÖÓªÑøËØµÝËÍͨµÀ£¬£¬Í¨¹ý½«ÓªÑøËØÖ±½Ó×¢ÈëÌåÄÚ£¬£¬¿ÉÒÔÈÆ¹ý賦µÀµÄÎüÊÕÀú³Ì£¬£¬Ö±½Ó½øÈëѪҺѭ»·£¬£¬¾ßÓиü¸ßµÄÉúÎïʹÓÃÂÊ¡£ÕâÖÖ·½Ê½³£ÓÃÓÚÐèҪѸËÙÔö²¹´ó×ÚÓªÑøËØµÄÇéÐΡ£


   ×ÜÖ®£¬£¬ÓªÑøËصÝËÍͨµÀÊǽ«ÓªÑøÎïÖÊ´ÓÍâ½çת´ïµ½ÌåÄÚϸ°ûµÄ;¾¶£¬£¬²î±ðµÄͨµÀ·½Ê½ÊÊÓÃÓÚ²î±ðµÄÇéÐκÍÐèÇó¡£


×÷Éõ¿ÚǻճĤµÝËÍͨµÀ


   ¿ÚÇ»ð¤Ä¤µÝËÍͨµÀÊÇÒ»ÖÖÁ¢ÒìµÄÒªÁ죬£¬ÓÃÓÚ½«ÓªÑøËØºÍÆäËûÉúÎï»îÐÔÎïÖÊת´ïµ½ÈËÌåÄÚ£¬£¬Í¨¹ý¿ÚÇ»ð¤Ä¤µÄÎüÊÕÀ´ÊµÏÖ¿ìËÙ¶øÓÐÓõÄÎüÊÕºÍת´ï¡£Õâһת´ï;¾¶Ö÷Òª·ÖΪÁ½ÖÖ·½Ê½£º£º£ºÉàϵÝËͺͼÕĤµÝËÍ¡£


   ÉàϵÝËÍÊǽ«ÓªÑøËØ»òÉúÎï»îÐÔÎïÖÊÖ±½Ó·ÅÖÃÔÚÉàÏÂð¤Ä¤Ï£¬£¬Ê¹Æäͨ¹ýð¤Ä¤½øÈëѪҺѭ»·¡£ÉàÏÂð¤Ä¤¸»ºñµÄѪ¹ÜÍøÂçºÍëϸѪ¹Ü¿ÉÒÔÔö½øÎïÖʵĿìËÙÎüÊÕ£¬£¬Èƹý賦µÀµÄÏû»¯ºÍ´úл£¬£¬´Ó¶øÊµÏÖ¸ü¸ßµÄÉúÎïʹÓÃÂʺ͸ü¿ìµÄЧ¹û¡£


   ¼ÕĤµÝËÍÊǽ«ÎïÖÊ·ÅÖÃÔÚ¼Õ²¿ÄÚ²àð¤Ä¤ÉÏ£¬£¬Í¨¹ý¼Õð¤Ä¤µÄÎüÊÕ½øÈëÑ­»·ÏµÍ³¡£ÕâÖÖ·½Ê½Ò²Äܹ»×èÖ¹ÎïÖÊÔÚ賦µÀÖеĽµ½âºÍ´úл£¬£¬Ìá¸ßÆäÉúÎïʹÓÃÂÊ¡£


   ÕâЩ¿ÚÇ»ð¤Ä¤µÝËÍͨµÀÔÚÓªÑøÔö²¹ºÍ±£½¡·½Ãæ¾ßÓÐDZÔÚÓ¦Óá£Í¨¹ýÕâЩ;¾¶£¬£¬ÈËÃÇ¿ÉÒÔ¸üÓÐÓõػñÈ¡ËùÐèµÄÓªÑøËØºÍÉúÎï»îÐÔÒòËØ£¬£¬´Ó¶øÊµÏÖ¸üºÃµÄ¿µ½¡ºÍÉúÑÄÖÊÁ¿¡£È»¶ø£¬£¬Ñ¡ÔñºÏÊʵĵÝËÍ·½Ê½ÐèҪ˼Á¿ÎïÖʵÄÌØÕ÷¡¢¡¢Ä¿µÄЧ¹ûºÍ¸öÌå²î±ð¡£Ëæ×ÅÑо¿µÄÒ»Ö±ÉîÈ룬£¬¿ÚÇ»ð¤Ä¤µÝËÍͨµÀÓÐÍûÔÚÓªÑøÔö²¹ÁìÓòʩչԽÀ´Ô½Ö÷ÒªµÄ×÷Óá£


ÉàÏÂð¤Ä¤ºÍ¼Õð¤Ä¤Ö®¼äµÄÉøÍ¸²î±ð


   ÉàÏÂð¤Ä¤ºÍ¼ÕĤ֮¼äµÄÆÊ½âºÍÉøÍ¸ÐÔ²î±ðÐèÒª²î±ðµÄµÝËÍͨµÀÉè¼Æ¡£ÓÉÓÚÉàÏÂð¤Ä¤¾ßÓиßÉøÍ¸ÐԺ͸»ºñµÄѪҺ¹©Ó¦£¬£¬Òò´ËËüÄܹ»¿ìËÙÎüÊÕ£¬£¬Ñ¸ËÙ±¬·¢×÷Ó㬣¬²¢¾ßÓнϸߵÄÉúÎïʹÓÃÂÊ¡£ÉàÏÂð¤Ä¤×îÊʺÏʹÓÃС¿ÅÁ£µÄµÝËÍͨµÀ£¬£¬ÔÚ¶Ìʱ¼äÄÚÒÔ¸ßŨ¶ÈÌṩ»¯ºÏÎï¡£ÄÉÃ×¼¶£¨½éÓÚ20µ½200ÒÚ·ÖÖ®Ò»Ã×Ö®¼ä£©µÄ¹ÌÌåÖ¬ÖʺÍÒºµÎÖ¬ÖÊÄÉÃ×Çò¾ßÓÐÀíÏëµÄ×é³ÉºÍ·Ö×ӽṹ£¬£¬ÊÊÓÃÓÚÉàϵÝËÍͨµÀ¡£


   ¼ÕĤµÄÉøÍ¸ÐÔÏÔ×ŵÍÓÚÉàÏÂÇøÓò£¬£¬²»¾ß±¸ÉàϵÝË͵ĿìËÙÎüÊÕºÍÓÅÔ½ÉúÎïʹÓÃÂÊ¡£ÔÚ¶àÏî½ÏÁ¿Ñо¿ÖУ¬£¬ÉàϵÝËÍЧ¹û±È¼ÕĤµÝË͸üΪÓÐÓá£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDMvM2QwODg5ZjRhYzkyOTFhODU4ZGM0Y2VhYjIzN2MwNDUucG5n


×÷ÉõÄÉÃ×Çò


   Í¨¹ý¿ÚÇ»ð¤Ä¤µÝËÍÓªÑøÔö²¹¼ÁºÍ±£½¡Æ·µÄ½â¾ö·½°¸ÔÚÓÚ½«ÉúÎﻯºÏÎï·â×°µ½¸ßÉøÍ¸ÐÔµÄÖ¬ÖÊÄÉÃ×ÇòÖС£ÕâЩÄÉÃ×Çò¿ÉÒÔͨ¹ýµÎ¹ÜÇáËɵØÍ¶·Åµ½¿ÚÇ»µÄÉàÏÂð¤Ä¤£¬£¬ÒÔ±ã¿ìËÙ±»ÎüÊÕ½øÈëÑ­»·ÏµÍ³¡£


1.ÄÉÃ×ÇòµÄ»ù´¡£º£º£ºÄÉÃ×ÇòÊÇÓÉÇå¾²µÄÁ×Ö¬¡¢¡¢Ö¬·¾ËáºÍÍâò»îÐÔ¼Á×é³ÉµÄ£¬£¬¾ßÓиßÉøÍ¸ÐԺͱ£»£»£»¤ÐÔ¡£Æä½¹µã×é³ÉÎïÖÊÁ×Ö¬õ£µ¨¼î·ÖÊý´¿¶ÈÁè¼Ý60%£¬£¬¿É¶¯Ì¬µØ±£»£»£»¤Ëù·â×°µÄÉúÎï»îÐÔÎïÖÊ¡£ÕâЩÄÉÃ×ÇòÓëÉúÎïĤºÍÖ¬ÂѰ׵ÄÖ÷ÒªÒòËØÏàͬ£¬£¬¶Ôϸ°ûĤ¸ß¶ÈÉøÍ¸£¬£¬Äܹ»ÓÐÓõطâ×°ÖÖÖÖÉúÎï»îÐÔÎïÖÊ£¬£¬ÊµÏÖ¿ìËٵĿÚÇ»ð¤Ä¤×ª´ï¡£


2.ÑÇ΢Ã×ÒþÐÎÇòÌ壺£º£ºÄÉÃ×ÇòµÄ³ß´ç¶ÔÆäЧ¹ûÖÁ¹ØÖ÷Òª£¬£¬Ö±¾¶ÔÚ20ÄÉÃ×µ½200ÄÉÃ×Ö®¼äµÄÄÉÃ×ÇòÑ­»·Ê±¼ä½Ï³¤¡£¸üСµÄÄÉÃ×Çò¾ßÓÐÒþÉíÌØÕ÷£¬£¬¿ÉÒÔ×èÖ¹ÃâÒßϵͳ¼ì²â²¢ÌṩÒþ²ØÔØÌå¡£ËüÃǵÄÄÉÃ׳ߴçʹÆäÄܹ»´©Ô½Ï¸°ûºÍĤÆÁÕÏ£¬£¬ÉõÖÁ´©Ô½ÑªÄÔÆÁÕϽø×ÅÃÔ¾­ÏµÍ³ÇøÓò¡£ÄÉÃ×Çòת´ïϵͳ¾ßÓпìËÙÎüÊÕ¡¢¡¢Ìá¸ßÉúÎïʹÓöÈ¡¢¡¢¿ìËÙʩչ×÷Óᢡ¢Î¬³Ö¸ßѪ½¬Ë®Æ½ÒÔ¼°¸ÄÉÆÉúÎïЧӦµÈÓŵã¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDMvNzllNTE4OGU0ZTkxNTY2ZWZhMWZlMTFkZGMzY2ZhNDkucG5n


   ÄÉÃ×ÇòÒѱ»Ö¤Êµ¾ßÓÐÒÔÏÂÓÅÊÆ£º£º£º

1.ͨ¹ý¾­ð¤Ä¤ÎüÊÕµÝËÍÀ´ÔöÌíÉúÎïʹÓöÈ

2.¸ü³¤ÆÚµÄѪҺˮƽ£¬£¬¸ü¸ßµÄÉúÎïЧӦºÍ³ÖÐøÊ±¼ä¸ü³¤µÄÒæ´¦

3.¸ü¸ßЧµÄ·´Ó³£¬£¬ÔÊÐíïÔÌ­ÓÃÁ¿ºÍʹÓÃÆµÂÊ

4.½«±»×è¸ôµÄ»¯ºÏÎïÔËÊä´©¹ýѪÄÔÆÁÕϲ¢½øÈëÄԽṹ

5.¸ÄÉÆÓû§±ãµ±ÐÔ£¨ïÔ̭ʹÓÃÆµÂʺ͸üÈÝÒ××ñ´Ó£©

6.ÑÓÉìµÄÑ­»·°ëË¥ÆÚ£¨ÓëÒ©ÎïµÝË͸ººÉµÄÑо¿ÒѾ­Ö¤Êµ¿ÉÔöÌí100±¶£¬£¬´Ó¶øÏÔÖøÌá¸ßЧÁ¦-×î¸ß¿É´ï500±¶£©


Reference£º£º£º

1.Shojaei, A. H., Chang, R. K., Guo, X., Burnside, B. A., & Couch, R. A. (2001). Systemic drug delivery via the buccal mucosal route. Pharmaceutical technology25(6), 70-81.

2.Harris, D., & Robinson, J. R. (1992). Drug delivery via the mucous membranes of the oral cavity. Journal of pharmaceutical sciences81(1), 1-10.

3.Washington, N., Washington, C., & Wilson, C. (2000). Physiological pharmaceutics: barriers to drug absorption. CRC Press.

4.Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. J Control Release 2011 Jul 30;153(2):106-16.

5.Shojaei, A. H. (1998). Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharm Sci, 1(1), 15-30.

6.Hua, S. (2019). Advances in nanoparticulate drug delivery approaches for sublingual and buccal administration. Frontiers in pharmacology10, 1328.

7.Reza Mozafari, M., Johnson, C., Hatziantoniou, S., & Demetzos, C. (2008). Nanoliposomes and their applications in food nanotechnology. Journal of liposome research, 18(4), 309-327.

·ÖÏíµ½£º£º£º

ÔĶÁ¸ü¶àÎÄÕÂ
READ MORE

]]>
/?feed=rss2&p=40304 0
¶ÌÏÞÆÚÏõËáÑκ͹ϰ±ËáÁªºÏÔö²¹¶Ô¾«Ó¢ÈüͧÔË·¢¶¯Ô˶¯ÌåÏÖµÄÓ°Ïì /?p=40031 /?p=40031#comments Thu, 13 Mar 2025 06:06:01 +0000 http://www.jialanhai.com/?p=40031

ÉÅʳGABAµÄÉñÃØÊµÁ¦£º£º£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³×

2025-09-30 14:06
   ÔÚÔ˶¯¿ÆÑ§ÁìÓò£¬£¬Ì½Ñ°ÌáÉýÔË·¢¶¯ÌåÏÖµÄÓÐÓÃÒªÁìʼÖÕÊÇÈÈÃÅÑо¿Æ«Ïò¡£½üÆÚÒ»ÏîÕë¶Ô¾«Ó¢ÈüͧÔË·¢¶¯µÄÑо¿¾Û½¹ÓÚ¶ÌÏÞÆÚ£¨1ÖÜ£©¿Ú·þÁªºÏÔö²¹3.5¿ËÌð²Ë¸ùÌáÈ¡Îº¬500ºÁ¿ËÏõËáÑΣ©Óë6¿Ë¹Ï°±ËáËù±¬·¢µÄЧ¹û¡£¸ÃÑо¿½«ÆäÓëο½å¼ÁºÍµ¥¶ÀµÄÌð²Ë¸ùÔö²¹¼Á±ÈÕÕ£¬£¬ÉîÈë̽ÌÖ¶Ô¾«Ó¢ÄÐÐÔÈüͧÔË·¢¶¯ÓÐÑõÄÜÁ¦¡¢¡¢×ʵÁ¦ÒÔ¼°¸ßÇ¿¶È¹¦ÂʺͷåÖµ»®½°µÈ·½ÃæµÄÓ°Ïì¡£Ñо¿Ð§¹ûÏÔʾ£¬£¬ÕâÖÖÁªºÏÔö²¹ÔÚÒ»¶¨³Ì¶ÈÉϸÄÉÆÁËWingate²âÊÔºóµÄÈéËáɨ³ýÂʺÍÐÔÄܲâÊÔÖеķåÖµ¹¦ÂÊ£¬£¬²»¹ýÔÚÆäËûÈç×î´óÉãÑõÁ¿£¨VO?peak£©ºÍ×î´óÐÄÂʵÈÏà¹ØÐÄÀí²ÎÊýÉÏ£¬£¬²¢Î´³ÊÏÖ³öÏÔ×Ųî±ð1¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDMvOGYxMWQxYmE2YTk4Njk5NWNkN2QzNWYyNDkzMWIxODgucG5n


1.ÏõËáÑκ͹ϰ±ËáµÄ½éÉÜ
 
 1.1 ÏõËáÑÎ

   ÏõËáÑÎÊÇÒ»Ñõ»¯µª£¨NO£©µÄÖ÷ҪǰÌåÎïÖÊ¡£ÔÚÈËÌåÐÄÀíÀú³ÌÖУ¬£¬NO ¾ßÓм«ÎªÒªº¦µÄ×÷Ó㬣¬ËüÓëÔ˶¯ÌåÏֵĶà¸ö·½ÃæÏ¸ÃÜÏàÁ¬£¬£¬ÀýÈç¶Ô×î´óÉãÑõÁ¿£¨VO?max£©¡¢¡¢Ô˶¯¾­¼ÃÐÔÒÔ¼° VO?max µÄ·ÖÊýʹÓÃÂʵÈÖ¸±êÓÐ×ÅÖ÷ÒªÓ°Ïì¡£Ðí¶àÑо¿Î§ÈÆÏõËáÑÎÔö²¹¼ÁÕö¿ª£¬£¬Ïñ³£¼ûµÄ¸»º¬ÏõËáÑεÄÌð²Ë¸ù£¨BR£©ÌáÈ¡Î£¬ÆäÔö²¹ºóÄܹ»ÌáÉýÑ­»·ÏõËáÑΣ¨NO??£©Ë®Æ½£¬£¬½ø¶øÔö½ø NO µÄÌìÉú¡£NO µÄ±¬·¢ÓÐÖúÓÚѪ¹ÜÊæÕÅ£¬£¬ÔöÌíѪҺÁ÷Ïò¼¡Èâ×éÖ¯£¬£¬´Ó¶ø¸ÄÉÆÑõÆø¹©Ó¦£¬£¬ÎªÔ˶¯Öеļ¡ÈâÌṩ¸ü¸»×ãµÄÄÜÁ¿Ö§³Ö£¬£¬ÔÚÔ˶¯Àú³ÌÖÐʩչ×ÅÖ÷ÒªµÄÐÄÀíµ÷Àí¹¦Ð§¡£

 1.2 ¹Ï°±Ëá

   ¹Ï°±ËᣨCIT£©×÷ΪһÖÖ°±»ùËᣬ£¬¾ßÓÐDZÔÚµÄÔöÇ¿Ô˶¯ÄÜÁ¦µÄÌØÕ÷¡£ËüÔÚÈËÌå´úлÖмÓÈëÖ÷ÒªµÄÐÄÀíÀú³Ì£¬£¬ÌØÊâÊÇÔÚÔ˶¯Àú³ÌÖУ¬£¬±»ÒÔΪ¿ÉÒÔïÔÌ­¸ßÇ¿¶ÈÔ˶¯Ê±´úѪҺÈéËáµÄ»ýÀÛºÍËáÖж¾µÄ±¬·¢¡£µ±ÑªÒºÖÐÈéËá»ýÀÛïÔ̭ʱ£¬£¬Äܹ»¼õÇἡÈâÆ£ÀÍ£¬£¬Ê¹¼¡ÈâÔÚÔ˶¯Öмá³Ö¸üºÃµÄÊÂÇé״̬£¬£¬½ø¶ø¿ÉÄÜÌá¸ßÓÐÑõÄÜÁ¦ºÍ¼¡ÈâʵÁ¦µÄ±¬·¢¡£±ðµÄ£¬£¬CIT»¹¾ßÓд̼¤¼¡ÈâÂѰ×ÖʺϳɵÄ×÷Ó㬣¬Õâ¹ØÓÚά³ÖºÍÔöÇ¿¼¡ÈâÖÊÁ¿¡¢¡¢ÌáÉý¼¡ÈâʵÁ¦¾ßÓÐÖ÷ÒªÒâÒ壬£¬ÔÚÔ˶¯ÓªÑøÁìÓòÊܵ½ÁËÆÕ±é¹Ø×¢¡£


2.ÏõËáÑκ͹ϰ±Ëá¶ÔÔË·¢¶¯µÄÓ°Ïì
 
 2.1µ¥¶ÀÔö²¹µÄЧ¹û

   ÒÔÍùµÄÑо¿Åú×¢£¬£¬µ¥¶ÀÔö²¹BR¶ÔÔË·¢¶¯µÄÔ˶¯ÌåÏÖÓÐÒ»¶¨µÄÆð¾¢Ó°Ïì¡£ÀýÈ磬£¬ÔÚһЩÄÍÁ¦ÏîÄ¿ÖУ¬£¬ÔË·¢¶¯ÔÚÔ˶¯Ç°ÉãÈëBR£¬£¬Äܹ»Ëõ¶ÌÍê³ÉÌØ¶¨¾àÀëµÄʱ¼ä£¬£¬ÈçÔÚ×ÔÐгµÏîÄ¿ÖÐïÔÌ­Íê³É4km¼ÆÊ±ÈüµÄ×Üʱ¼ä£¬£¬ÔÚÈüͧÏîÄ¿ÖÐÒ²ÓÐÀàËÆµÄÌáÉýÔ˶¯ÌåÏÖµÄÇéÐΡ£ÕâÖ÷Òª¹éÒòÓÚBR¶ÔѪ¹Ü¹¦Ð§µÄ¸ÄÉÆ£¬£¬ÔöÌíÁËѪҺ¹©Ó¦ºÍ×éÖ¯ÑõºÏ£¬£¬Ê¹µÃ¼¡ÈâÔÚÔ˶¯Àú³ÌÖÐÄܹ»»ñµÃ¸ü¸»×ãµÄÑõÆøºÍÓªÑøÎïÖÊ£¬£¬´Ó¶øÌá¸ßÔ˶¯Ð§ÂÊ¡£
   CITµ¥¶ÀÔö²¹Ê±£¬£¬ÔÚһЩÑо¿ÖÐÒ²ÏÔʾ³ö¶ÔÔ˶¯ÌåÏÖµÄÔö½ø×÷Óá£ÔÚÌØ¶¨µÄÔ˶¯²âÊÔÖУ¬£¬ÈçÔÚѵÁ·ÓÐËØµÄÄÐÐÔÖУ¬£¬Ô˶¯Ç°1СʱÉãÈëCIT¿ÉïÔÌ­Íê³É4kmËùÐèµÄʱ¼ä£»£»£»ÔÚ¿µ½¡ÄÐÐÔºÍÅ®ÐÔÖУ¬£¬Ô˶¯Ç°3СʱÉãÈëCITÄܹ»ÑÓÉìÔ˶¯ÖÁÁ¦½ßµÄʱ¼ä¡£ÕâÅú×¢CITÔÚÌá¸ßÓÐÑõÄÜÁ¦ºÍÄÍÁ¦·½Ãæ¾ßÓÐÒ»¶¨µÄDZÁ¦£¬£¬Æä»úÖÆ¿ÉÄÜÓëïÔÌ­ÈéËá»ýÀÛ¡¢¡¢¸ÄÉÆÄÜÁ¿´úлÒÔ¼°´Ì¼¤¼¡ÈâÂѰ×ÖʺϳɵÈÒòËØÓйØ¡£


 2.2ÁªºÏÔö²¹µÄDZÔÚÓÅÊÆ

   Ëæ×ÅÑо¿µÄÉîÈ룬£¬ÏõËáÑκ͹ϰ±ËáÁªºÏÔö²¹µÄЧ¹ûÖð½¥Êܵ½¹Ø×¢¡£´ÓÀíÂÛÉϽ²£¬£¬Á½Õß¶¼ÄÜÔö½øNOµÄ±¬·¢£¬£¬¿ÉÄܱ£´æÐ­Í¬×÷Óá£ÔÚһЩÑо¿ÖÐÒѾ­·¢Ã÷ÁËÕâÖÖÁªºÏÔö²¹µÄÆð¾¢Ð§¹û¡£ÀýÈ磬£¬ÔÚ¾­ÓÉѵÁ·µÄÌúÈËÈýÏîÔË·¢¶¯ÖУ¬£¬¾ÙÐÐ9ÖܵÄÁªºÏÔö²¹ºó£¬£¬ÓÐÑõÄÜÁ¦ºÍ×î´ó¼°ÄÍʵÁ¦Á¦¶¼ÓÐËùÌá¸ß£¬£¬Í¬Ê±ÔÚÉú»¯²ÎÊý·½ÃæÒ²ÏÔʾ³ö¸üºÃµÄ»Ö¸´×´Ì¬¡£Õâ˵Ã÷ÁªºÏÔö²¹¿ÉÄÜͨ¹ý¶àÖÖÐÄÀí;¾¶ÅäÏàÖúÓ㬣¬¶ÔÔË·¢¶¯µÄÔ˶¯ÌåÏÖºÍÉíÌå»Ö¸´±¬·¢¸üÏÔÖøµÄÓ°Ï죬£¬ÎªÔË·¢¶¯µÄѵÁ·ºÍ½ÇÖðÌṩ¸üÓÐÁ¦µÄÖ§³Ö¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDMvMjQ5ZWZjMDNiMDEzMzI1ZTQwODFlYTExMzdjYmMxZGYucG5n

3.Õ¹Íû

   ËäÈ»±¾´ÎÑо¿ÔÚ¶ÌÏÞÆÚÁªºÏÔö²¹·½ÃæÈ¡µÃÁËÒ»¶¨µÄЧ¹û£¬£¬µ«ÈÔ±£´æÒ»Ð©¾ÖÏÞÐÔ¡£ÀýÈ磬£¬Ñо¿ÖÐδÉèÖýöÔö²¹CITµÄ±ÈÕÕ×飬£¬ÕâʹµÃÄÑÒÔÖ±½Ó½ÏÁ¿CITµ¥¶À×÷ÓÃÓëÁªºÏÔö²¹µÄЧ¹û²î±ð¡£±ðµÄ£¬£¬Ñо¿½öͨ¹ýѪҺָ±êºÍÔ˶¯ÌåÏÖ²âÊÔ¾ÙÐÐÆÀ¹À£¬£¬È±·¦¶Ô¼¡Èâ×éÖ¯µÄÖ±½ÓÆÊÎö£¬£¬È缡Èâ»î¼ìµÈ£¬£¬ÕâÏÞÖÆÁË¶ÔÆä×÷ÓûúÖÆµÄÉîÈëÏàʶ¡£Í¬Ê±£¬£¬Î´Ë¼Á¿¸öÌ峦µÀ΢ÉúÎïȺ¶ÔÏõËáÑκ͹ϰ±Ëá´úлµÄÓ°Ï죬£¬¶øÕâ¿ÉÄÜÔÚÔö²¹¼ÁµÄЧ¹ûÖÐÆðµ½Ö÷Òª×÷Óá£

   Î´À´µÄÑо¿¿ÉÒÔÕë¶ÔÕâЩȱ·¦Õö¿ª¡£Ê×ÏÈ£¬£¬Ó¦Éè¼Æ¸üÖÜÈ«µÄʵÑé·½°¸£¬£¬°üÀ¨²î±ð¼ÁÁ¿¡¢¡¢²î±ðÔö²¹Ê±¼äÒÔ¼°²î±ðÔ˶¯ÏîÄ¿µÄÑо¿£¬£¬ÒÔÈ·¶¨×î¼ÑµÄÔö²¹Õ½ÂÔ¡£Æä´Î£¬£¬ÉîÈë̽ÌÖÁªºÏÔö²¹µÄ×÷ÓûúÖÆ£¬£¬Í¨¹ý¶Ô¼¡Èâ´úл¡¢¡¢Éñ¾­¼¡È⹦ЧÒÔ¼°ÐÄѪ¹ÜϵͳµÄ×ÛºÏÑо¿£¬£¬ÖÜÈ«ÏàʶÆä¶ÔÔ˶¯ÌåÏÖµÄÓ°Ïì¡£±ðµÄ£¬£¬»¹Ó¦¹Ø×¢²î±ðÐԱ𡢡¢ÄêËêºÍÑ·üç®Æ½µÄÔË·¢¶¯´ºÁªºÏÔö²¹µÄ·´Ó³²î±ð£¬£¬Îª¸öÐÔ»¯µÄÓªÑøÔö²¹Ìṩ¿ÆÑ§ÒÀ¾Ý¡£×ÜÖ®£¬£¬ÏõËáÑκ͹ϰ±ËáÁªºÏÔö²¹ÔÚÔË·¢¶¯Ô˶¯ÌåÏÖÌáÉý·½Ãæ¾ßÓÐÁÉÀ«µÄÑо¿Ô¶¾°£¬£¬Î´À´µÄÑо¿ÓÐÍûΪÔË·¢¶¯µÄѵÁ·ºÍÓªÑøÖ§³ÖÌṩ¸ü¾«×¼¡¢¡¢ÓÐÓõÄÖ¸µ¼¡£

²Î¿¼ÎÄÏ×:

1.Viribay A, Alcantara JMA, L¨®pez I, Mielgo-Ayuso J, Casta?eda-Babarro A. Impact of a short-term nitrate and citrulline co-supplementation on sport performance in elite rowers: a randomized, double-blind, placebo-controlled crossover trial. Eur J Appl Physiol. 2024;124(6):1911-1923. doi:10.1007/s00421-024-05415-4

·ÖÏíµ½£º£º£º

ÔĶÁ¸ü¶àÎÄÕÂ
READ MORE

]]>
/?feed=rss2&p=40304 0